No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
5286 |
4. Check minimum number of eventsNone |
5286 |
5. Include endpointsNone |
5286 |
6. Filter based on genotype QC (FinnGen only) |
5286 |
Control definitions (FinnGen only)
- Control exclude
- I9_STR_EXH, I9_TIA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- I60-I69
- Name in latin
- Haemorrhagia intracerebralis
Similar endpoints
↥List of similar endpoints to
Intracerebral haemorrhage
based on the number of shared cases.
Similar with more cases:
- Nontraumatic intracranial haemmorrhage
- Cerebrovascular diseases (FINNGEN)
- Cerebrovascular diseases
- Bleeding
- STROKE
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 79457 | 36219 | 41747 |
| Only index persons | 46894 | 21914 | 24980 |
| Unadjusted period prevalence (%) | |||
| Whole population | 1.11 | 1.04 | 1.17 |
| Only index persons | 0.88 | 0.81 | 0.95 |
| Median age at first event (years) | |||
| Whole population | 70.68 | 74.26 | 67.66 |
| Only index persons | 71.33 | 75.26 | 67.88 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5286 | 2089 | 3197 |
| Unadjusted period prevalence (%) | 1.13 | 0.71 | 1.41 |
| Median age at first event (years) | 70.61 | 70.70 | 70.56 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4719
- Matched controls
- 47179
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
16384.0
323.0
2026
*
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
+∞
323.0
769
*
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
324.1
323.0
1116
45
K90
ICPC
Stroke/cerebrovascular accident
40.3
323.0
548
153
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
46.5
323.0
519
125
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
6139.4
323.0
1945
5
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
158.2
323.0
980
78
AA1AD
NOMESCO Finland
CT of head and brain
6.6
323.0
2325
6024
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
18.1
323.0
823
543
I61.4
ICD-10 Finland
Intracerebral haemorrhage in cerebellum
+∞
313.0
297
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
9.1
299.5
672
844
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
1542.6
296.7
286
*
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
27.7
247.5
345
134
I61.8
ICD-10 Finland
Other intracerebral haemorrhage
2348.6
243.6
234
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.5
238.1
1393
5081
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
803.5
235.5
230
*
N03AX14
ATC
levetiracetam; systemic
14.4
227.8
399
300
XA800
NOMESCO Finland
Neuropsychological investigation
11.6
208.1
404
379
N18
ICPC
Paralysis/weakness
18.6
199.3
315
181
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
44.2
199.1
248
59
I61.5
ICD-10 Finland
Intracerebral haemorrhage, intraventricular
+∞
195.1
186
*
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
331.7
191.8
193
6
I61.3
ICD-10 Finland
Intracerebral haemorrhage in brain stem
+∞
187.7
179
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
9.2
184.2
404
474
I61.6
ICD-10 Finland
Intracerebral haemorrhage, multiple localized
1937.0
183.4
177
*
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
8.0
182.8
440
601
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
16.2
181.2
301
197
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
25.1
177.0
253
106
K91
ICPC
Cerebrovascular disease
26.7
170.2
239
94
R4120
NOMESCO Finland
Occupational therapy
6.2
165.1
478
845
S06.3
ICD-10 Finland
Focal brain injury
15.5
163.8
277
189
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
13.7
159.5
284
219
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
157.3
1130
4562
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
14.6
155.9
270
195
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
5.9
155.6
465
854
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
12.5
153.2
285
242
AAB30
NOMESCO Finland
Evacuation of spontaneous intracranial haematoma
1522.8
149.7
145
*
AAF00
NOMESCO Finland
Ventriculostomy
32.0
142.9
191
62
N03AF02
ATC
oxcarbazepine; oral
8.1
136.2
321
420
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.8
135.5
494
1132
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
29.7
120.6
164
57
I61.2
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, unspecified
+∞
117.1
112
*
I61
ICD-10 Finland
Intracerebral haemorrhage
175.7
114.9
120
7
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.0
112.2
386
826
4310A
ICD-9 Finland
Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS CUM HYPERTONIA]
+∞
107.7
103
*
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
1061.3
106.7
104
*
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
18.0
105.2
167
96
R47.0
ICD-10 Finland
Dysphasia and aphasia
32.5
97.9
130
41
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
+∞
96.1
92
*
H53.4
ICD-10 Finland
Visual field defects
9.2
95.3
206
232
N03AG01
ATC
valproic acid; systemic, rectal
4.3
94.1
377
938
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
6.6
91.2
245
386
R4150
NOMESCO Finland
Neuropsychological rehabilitation
45.8
90.9
112
25
R4130
NOMESCO Finland
Speech therapy
8.9
90.5
200
234
4311A
ICD-9 Finland
Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS HYPERTONIA NON INDICAT]
+∞
88.8
85
*
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
231.7
88.7
91
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
87.4
1672
10378
WX892
NOMESCO Finland
Monitored bed care
3.2
86.9
501
1683
AAD15
NOMESCO Finland
Evacuation of traumatic intracerebral haematoma
117.2
85.2
92
8
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
10.2
84.0
171
173
Z2445
NOMESCO Finland
Psychologist
6.8
83.2
220
339
N19
ICPC
Speech disorder
15.6
82.5
138
91
4319X
ICD-9 Finland
Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS NUD]
+∞
82.5
79
*
N03AB02
ATC
phenytoin; systemic
9.3
80.2
172
191
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
770.3
77.5
76
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.8
76.0
3009
23434
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
16.4
74.7
122
76
N03AF01
ATC
carbamazepine; oral, rectal
3.5
73.5
368
1106
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
83.5
73.2
82
10
PA2AD
NOMESCO Finland
CT angiography of brain
31.9
72.9
97
31
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
21.4
70.6
105
50
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
+∞
69.9
67
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.2
67.6
379
1239
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.9
67.4
196
342
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.8
67.4
236
511
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
7.9
67.1
158
205
T90.5
ICD-10 Finland
Sequelae of intracranial injury
10.5
67.0
134
131
R1260
NOMESCO Finland
Evaluation of communicative skills
7.6
67.0
162
219
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.6
65.7
240
543
R51.80
ICD-10 Finland
Headache
2.5
64.1
542
2297
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
63.1
934
5138
I63.8
ICD-10 Finland
Other cerebral infarction
100.0
63.0
69
7
D68.3
ICD-10 Finland
Haemorrhagic disorder due to circulating anticoagulants
18.6
62.4
97
53
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
8.9
62.1
136
157
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
7.4
58.9
145
202
C08CA01
ATC
amlodipine; oral
1.7
57.7
1862
13193
ZXD05
NOMESCO Finland
Urgent procedure
1.7
57.6
1468
9708
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
22.8
57.1
83
37
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
17.6
56.8
90
52
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
10.8
56.6
111
105
I69.2
ICD-10 Finland
Sequelae of other nontraumatic intracranial haemorrhage
46.6
56.5
69
15
TKC20
NOMESCO Finland
Catheterisation of bladder
2.5
56.2
487
2082
A28
ICPC
Limited function/disability NOS
1.9
54.3
953
5553
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
54.1
834
4629
N03AX18
ATC
lacosamide; systemic
20.8
53.5
80
39
W19
ICD-10 Finland
Unspecified fall
2.3
52.8
524
2402
205
Kela drug reimbursment
Chronic hypertension
1.6
51.6
1698
11990
B01AA03
ATC
warfarin; systemic
1.7
50.4
1295
8508
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
18.0
49.7
78
44
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
27.5
49.5
68
25
AA5PD
NOMESCO Finland
CT examination of brain pefusion
37.5
49.4
63
17
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
48.9
1423
9675
B01AC07
ATC
dipyridamole; systemic
2.8
48.3
326
1203
WX730
NOMESCO Finland
Conventional respirator
5.1
48.1
156
311
G40.10
ICD-10 Finland
Simple partial seizures
13.3
48.0
85
65
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
12.7
46.6
84
67
PA7BD
NOMESCO Finland
CT angiography of neck and brain
8.3
46.3
105
129
G41.9
ICD-10 Finland
Status epilepticus, unspecified
16.2
46.0
75
47
Q28.2
ICD-10 Finland
Arteriovenous malformation of cerebral vessels
24.4
45.8
65
27
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
17.8
45.8
72
41
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
232.0
45.0
46
*
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
4.2
45.0
176
426
C09AA05
ATC
ramipril; oral
1.6
42.4
1309
8970
N28
ICPC
Limited function/disability (N)
5.7
41.8
124
223
R4110
NOMESCO Finland
Physiotherapy
1.7
41.8
1130
7464
L28
ICPC
Limited function/disability (L)
1.8
41.4
843
5105
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
23.9
41.4
59
25
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
6.9
41.3
105
154
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
9.5
41.2
86
92
Z3226
NOMESCO Finland
Physiotherapist
1.8
41.1
811
4866
FFM32
NOMESCO Finland
Occlusion or excision of atrial appendage transvenously with a closing device
58.0
39.3
46
8
G91.0
ICD-10 Finland
Communicating hydrocephalus
10.9
39.2
76
71
I60.8
ICD-10 Finland
Other subarachnoid haemorrhage
26.8
38.5
53
20
SPAT1216
SPAT
Assessment of functional ability
1.8
38.4
824
5065
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
27.6
38.1
52
19
G81.9
ICD-10 Finland
Hemiplegia, unspecified
10.6
37.7
74
71
SPAT1229
SPAT
Assessment of need for aid
2.1
37.6
457
2279
FFW96
NOMESCO Finland
Other operation on atria
33.0
37.5
49
15
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
12.9
36.5
65
51
S06.0
ICD-10 Finland
Concussion
2.1
36.3
452
2279
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.4
36.1
337
1487
183
Kela drug reimbursment
Lamotrigin and topiramate
10.7
36.0
70
66
B01AC04
ATC
clopidogrel; oral
1.8
35.7
733
4432
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.3
35.5
342
1534
R47.1
ICD-10 Finland
Dysarthria and anarthria
9.3
35.1
74
81
GBB00
NOMESCO Finland
Tracheostomy
5.1
34.1
110
219
I60.2
ICD-10 Finland
Subarachnoid haemorrhage from anterior communicating artery
12.1
33.3
61
51
R42
ICD-10 Finland
Dizziness and giddiness
1.6
33.0
947
6298
R41.0
ICD-10 Finland
Disorientation, unspecified
2.8
32.4
216
789
43190
ICD-8 Finland
Cerebral haemorrhage, Intracerebralis, hypertonia non indicata
+∞
32.3
31
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
31.7
1361
9962
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
4.2
31.5
124
303
S01.0
ICD-10 Finland
Open wound of scalp
2.1
31.5
394
1987
R53
ICD-10 Finland
Malaise and fatigue
1.6
31.0
912
6091
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.4
30.6
277
1203
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.4
30.6
282
1235
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.2
30.6
342
1643
SPAT1231
SPAT
Assessment of adjustments needed in living environment
3.4
30.4
154
467
N88
ICPC
Epilepsy
12.1
30.1
55
46
Z2446
NOMESCO Finland
Social worker
2.3
29.7
289
1299
I62.9
ICD-10 Finland
Intracranial haemorrhage (nontraumatic), unspecified
17.8
29.6
46
26
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
21.7
29.5
43
20
R55
ICD-10 Finland
Syncope and collapse
1.8
29.3
550
3218
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
4.8
29.2
99
209
G40
ICD-10 Finland
Epilepsy
8.7
29.1
63
73
N05BA09
ATC
clobazam; oral
13.6
28.9
50
37
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.0
28.9
379
1948
C07AB07
ATC
bisoprolol; oral
1.4
28.8
2304
18995
G45.3
ICD-10 Finland
Amaurosis fugax
22.9
28.7
41
18
ZXD35
NOMESCO Finland
Usual procedure
2.7
28.6
202
765
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
28.3
800
5271
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
28.2
711
4539
C02AC05
ATC
moxonidine; oral
2.4
28.1
246
1050
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.6
27.8
754
4912
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.0
27.5
113
288
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.7
27.5
196
748
A06AD11
ATC
lactulose; oral
1.6
27.3
833
5590
N05AH04
ATC
quetiapine; oral
1.7
27.3
565
3405
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.2
27.3
145
456
I69.4
ICD-10 Finland
Sequelae of stroke, not specified as haemorrhage or infarction
53.6
27.2
32
6
Z50.5
ICD-10 Finland
Speech therapy
6.1
27.1
75
125
43199
ICD-8 Finland
Cerebral haemorrhage, Without mention of hypertension
+∞
27.1
26
*
AAD05
NOMESCO Finland
Evacuation of acute subdural haematoma
7.6
26.7
63
84
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
9.3
26.4
55
60
M03BX01
ATC
baclofen; systemic
4.4
26.2
96
220
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
5.5
26.1
78
143
4318X
ICD-9 Finland
Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS ALIA DEFINITA]
+∞
26.1
25
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
8.3
26.0
58
71
S06.2
ICD-10 Finland
Diffuse brain injury
5.1
25.8
83
166
M01AH05
ATC
etoricoxib; oral
0.7
25.4
1302
16571
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
11.0
25.3
48
44
AAC40
NOMESCO Finland
Extirpation of intracranial arterio-venous malformation
70.2
24.8
28
*
I69
ICD-10 Finland
Sequelae of cerebrovascular disease
21.3
24.7
36
17
ZXY02
NOMESCO Finland
Neuropsychologist
13.1
24.6
43
33
N06AB04
ATC
citalopram; systemic
1.6
24.3
817
5602
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.5
24.2
195
798
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
15.7
24.1
39
25
D21
ICPC
Swallowing problem
4.3
24.0
91
216
AAL10
NOMESCO Finland
Intracranial endovascular thrombolysis
241.0
23.7
24
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.8
23.4
424
2447
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.8
23.2
441
2581
AA9CW
NOMESCO Finland
NA
20.1
23.0
34
17
C10AA01
ATC
simvastatin; oral
1.4
22.5
2105
17532
N05AX08
ATC
risperidone; systemic
1.8
22.3
395
2257
I60.6
ICD-10 Finland
Subarachnoid haemorrhage from other intracranial arteries
18.0
22.1
34
19
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
5.8
21.8
62
108
N06AX11
ATC
mirtazapine; oral
1.4
21.7
1158
8733
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.2
21.6
224
1040
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
21.4
412
2420
SPAT1254
SPAT
Administration of medicine
1.6
21.4
666
4470
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
23.2
21.2
30
13
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
4.4
21.1
77
177
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
8.2
21.1
47
58
XCK00
NOMESCO Finland
Perimetry
1.9
21.0
311
1671
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.9
20.9
306
1636
43100
ICD-8 Finland
Cerebral haemorrhage, Intracerebralis, cum hypertonia
+∞
20.8
20
*
4351A
ICD-9 Finland
Transient cerebral ischaemia, Vertebral artery syndrome
+∞
20.8
20
*
XX2BT
NOMESCO Finland
Other injection with X-ray guidance
19.5
20.8
31
16
XA400
NOMESCO Finland
EEG
8.1
20.6
46
57
Z02.4
ICD-10 Finland
Examination for driving licence
0.7
20.6
603
8537
PA2VT
NOMESCO Finland
Intravascular evacuation of brain artery embolus
210.7
20.6
21
*
AAA27
NOMESCO Finland
Insertion of intracerebral pressure monitoring device
30.1
20.5
27
9
SPAT1234
SPAT
Support of social functional capacity
2.0
20.5
277
1437
K89
ICPC
Transient cerebral ischaemia
10.1
20.3
40
40
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.3
20.2
76
180
N06AB10
ATC
escitalopram; oral
1.6
20.2
569
3723
I68.0
ICD-10 Finland
Cerebral amyloid angiopathy
48.2
20.1
24
5
A98
ICPC
Health maint/preventive medicine
0.7
19.9
3167
34676
N80
ICPC
Head injury other
3.6
19.9
91
257
S06.8
ICD-10 Finland
Other intracranial injuries
14.4
19.8
33
23
TPX22
NOMESCO Finland
Intravenous arterial thrombolysis
12.6
19.8
35
28
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
19.7
214
1015
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
5.2
19.6
61
119
WX872
NOMESCO Finland
Intensive care
2.1
19.6
229
1122
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.0
19.5
263
1361
I63
ICD-10 Finland
Cerebral infarction
13.8
19.5
33
24
N03AX09
ATC
lamotrigine; oral
2.8
19.1
123
444
I68.0*E85.9
ICD-10 Finland
Cerebral amyloid angiopathy
26.1
19.1
26
10
G91.1
ICD-10 Finland
Obstructive hydrocephalus
8.4
18.8
41
49
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
18.8
520
3384
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
18.8
631
4302
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.4
18.7
168
729
A12BA01
ATC
potassium chloride; oral
1.8
18.7
311
1740
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.2
18.5
193
900
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.5
18.4
603
4088
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.0
17.9
228
1157
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.8
17.9
308
1746
4300A
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]
6.6
17.6
45
69
P20
ICPC
Memory disturbance
1.5
17.6
644
4477
TPH07
NOMESCO Finland
Cathetrisation of artery
1.6
17.5
442
2804
C09AA02
ATC
enalapril; systemic
1.4
17.5
1011
7691
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
17.4
173
791
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.0
17.2
216
1090
G81.1
ICD-10 Finland
Spastic hemiplegia
31.5
17.0
22
7
PA6AD
NOMESCO Finland
CT of neck arteries
6.3
16.8
44
70
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.9
16.8
248
1333
S02.00
ICD-10 Finland
Fracture of the upper part of the head closed
7.2
16.7
40
56
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.6
16.4
434
2785
F80.1
ICD-10 Finland
Expressive language disorder
8.2
16.4
36
44
R11
ICD-10 Finland
Nausea and vomiting
1.8
16.4
306
1779
YKA02
NOMESCO Finland
Excision of kidneys from cadaver donor
40.2
16.3
20
5
AAK00
NOMESCO Finland
Cranioplasty
30.1
16.1
21
7
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
15.9
812
6025
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
15.8
316
1875
C03CA01
ATC
furosemide; systemic
1.3
15.7
1649
13736
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
5.6
15.6
45
81
4359X
ICD-9 Finland
Transient cerebral ischaemia, Unspecified transient cerebral ischaemia
+∞
15.6
15
*
G40.89
ICD-10 Finland
Other epilepsy
9.2
15.6
32
35
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
3.0
15.6
89
296
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
17.2
15.6
24
14
2161
FHL
Neck ligation, big brain
6.3
15.6
41
66
RS221
NOMESCO Finland
NA
3.6
15.6
71
202
G93.90
ICD-10 Finland
Brain death
160.4
15.5
16
*
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
6.5
15.3
39
60
Z3231
NOMESCO Finland
Registered nurse
1.4
15.3
1073
8406
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.3
15.3
78
242
XX3XW
NOMESCO Finland
NA
6.3
15.3
40
64
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
15.2
603
4253
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.4
15.2
764
5645
F05.9
ICD-10 Finland
Delirium, unspecified
2.5
15.2
115
459
N30.0
ICD-10 Finland
Acute cystitis
1.5
15.1
503
3417
JDB10
NOMESCO Finland
Percutaneous gastrostomy
3.5
15.1
70
202
WX704
NOMESCO Finland
Intubation
1.8
15.0
249
1394
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
3.4
15.0
73
219
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
13.9
15.0
25
18
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
3.6
15.0
66
183
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
6.8
14.9
37
55
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
14.9
1418
11626
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
9.4
14.9
30
32
ZXE20
NOMESCO Finland
More than three and less than five hours
1.5
14.9
564
3943
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.5
14.7
460
3080
L01AX03
ATC
temozolomide; systemic
5.7
14.6
41
72
4350A
ICD-9 Finland
Transient cerebral ischaemia, Basilar artery syndrome
+∞
14.6
14
*
C07AB02
ATC
metoprolol; systemic
1.3
14.5
1087
8593
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.9
14.5
215
1158
N05BA01
ATC
diazepam; systemic, rectal
1.5
14.3
518
3583
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
5.7
14.3
40
70
P15
ICPC
Chronic alcohol abuse
2.8
14.3
89
317
PA2KT
NOMESCO Finland
Endovascular closure of brain aneurysm
17.0
14.3
22
13
C10AA05
ATC
atorvastatin; oral
1.3
14.2
1537
12809
315
Kela drug reimbursment
Clopidogrel
4.1
14.2
54
132
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
9.1
14.2
29
32
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.6
14.1
385
2492
G41.2
ICD-10 Finland
Complex partial status epilepticus
14.4
14.0
23
16
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
8.8
13.9
29
33
F10.24
ICD-10 Finland
Alcohol depence active use
3.9
13.9
57
149
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.1
13.8
153
736
F01.9
ICD-10 Finland
Vascular dementia, unspecified
2.7
13.8
96
366
4019X
ICD-9 Finland
Essential hypertension, Unspecified
2.0
13.8
186
968
AAK80
NOMESCO Finland
Partial excision of skull cap
53.4
13.8
16
*
WW806
NOMESCO Finland
Transfer from treating institution to lower-Level care, accompanied by doctor
53.4
13.8
16
*
S06.9
ICD-10 Finland
Intracranial injury, unspecified
5.2
13.7
42
82
C08CA02
ATC
felodipine; oral
1.5
13.6
470
3213
S02.11
ICD-10 Finland
Fracture of base of skull, open
6.4
13.6
35
55
H53.2
ICD-10 Finland
Diplopia
2.5
13.6
110
454
43198
ICD-8 Finland
Cerebral haemorrhage, Aliandefinita, hypertonia non indicata
+∞
13.5
13
*
RS313
NOMESCO Finland
NA
7.9
13.5
30
38
WX882
NOMESCO Finland
High dependency care
2.3
13.5
122
534
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
3.8
13.5
56
148
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
13.5
1071
8530
C08CA05
ATC
nifedipine; systemic
1.6
13.5
325
2039
YJA10
NOMESCO Finland
Excision of liver from cadaver donor
140.3
13.4
14
*
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.9
13.4
212
1166
PA2MT
NOMESCO Finland
Endovascular closure of very extensive brain aneurysm
18.2
13.3
20
11
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.6
13.3
96
374
G45.8
ICD-10 Finland
Other transient cerebral ischaemic attacks and related syndromes
21.2
13.3
19
9
GBB03
NOMESCO Finland
Percutaneous tracheostomy
21.2
13.3
19
9
XX3DW
NOMESCO Finland
Time consuming IT work
1.6
13.2
365
2368
C03AA03
ATC
hydrochlorothiazide; oral
1.5
13.1
461
3166
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
13.1
568
4076
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.7
13.1
90
341
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
7.4
12.9
30
41
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
6.9
12.8
31
45
W10
ICD-10 Finland
Fall on and from stairs and steps
1.9
12.6
190
1027
A29
ICPC
General symptom/complaint other
1.5
12.5
437
2997
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.7
12.5
285
1759
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.6
12.5
331
2126
S42.2
ICD-10 Finland
Fracture of upper end of humerus
1.8
12.3
195
1074
127
Kela drug reimbursment
Transplant complication
3.6
12.3
55
156
SPAT1252
SPAT
Overall medication plan or its review
1.6
12.2
309
1960
N29
ICPC
Neurological sympt/complt other
2.7
12.1
82
309
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.1
12.0
139
682
I60.3
ICD-10 Finland
Subarachnoid haemorrhage from posterior communicating artery
11.0
12.0
22
20
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.2
12.0
117
534
L04AA06
ATC
mycophenolic acid; systemic
3.3
11.8
59
182
TAB00
NOMESCO Finland
Lumbar puncture
2.1
11.8
126
597
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
11.7
410
2811
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
11.7
1044
8427
APM
HP
Auricle closure
65.1
11.6
13
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.8
11.6
211
1219
S06.4
ICD-10 Finland
Epidural haemorrhage
8.6
11.5
24
28
TK800
NOMESCO Finland
Hemodialysis
2.4
11.5
92
382
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
5.1
11.5
35
69
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.0
11.5
66
224
G942, I615
ICD-10 Finland
NA
+∞
11.5
11
*
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
5.4
11.4
33
61
A04
ICPC
Weakness/tiredness general
1.4
11.4
480
3423
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
7.8
11.3
25
32
C09BA02
ATC
enalapril and diuretics; systemic
1.5
11.3
399
2740
WYA20
NOMESCO Finland
Home visit
2.4
11.3
90
373
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
10.5
11.2
21
20
G41.0
ICD-10 Finland
Grand mal status epilepticus
9.6
11.2
22
23
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
7.3
11.2
26
36
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.8
11.0
45
119
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.7
10.9
248
1531
2BD01
NOMESCO Finland
NA
6.6
10.9
27
41
PA2HT
NOMESCO Finland
Extensive embolisation of arterio-venous malformation of the brain
43.4
10.9
13
*
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.6
10.9
239
3610
SPAT1293
SPAT
Other function in accordance with rehabilitation guidance nomenclature
5.0
10.9
34
69
R40.2
ICD-10 Finland
Coma, unspecified
3.4
10.9
51
151
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.5
10.7
80
320
A10AE04
ATC
insulin glargine; parenteral
1.5
10.6
358
2435
F03
ICD-10 Finland
Unspecified dementia
1.6
10.6
270
1722
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
10.0
10.5
20
20
K78
ICPC
Atrial fibrillation/flutter
1.5
10.5
369
2537
PA2YT
NOMESCO Finland
Cerebral artery PTA with stent
14.2
10.5
17
12
43300
ICD-8 Finland
Cerebral thrombosis, Wtih hypertension (benign)
+∞
10.4
10
*
43399
ICD-8 Finland
Cerebral thrombosis, Without mention of hypertension
+∞
10.4
10
*
4341A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral embolism
+∞
10.4
10
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.4
10.3
485
3532
B01AB05
ATC
enoxaparin; parenteral
1.3
10.3
1141
9462
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.6
10.2
237
1476
R50.9
ICD-10 Finland
Fever, unspecified
1.4
10.2
493
3610
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.2
10.0
101
469
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
2.6
10.0
69
265
G41.8
ICD-10 Finland
Other status epilepticus
20.0
9.8
14
7
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.9
9.8
143
770
M01AE01
ATC
ibuprofen; systemic, rectal
0.8
9.7
2908
31253
R20.2
ICD-10 Finland
Paraesthesia of skin
1.8
9.6
159
894
OAB43
SPAT
NA
0.5
9.6
72
1429
I67.8
ICD-10 Finland
Other specified cerebrovascular diseases
6.8
9.6
23
34
Z94.0
ICD-10 Finland
Kidney transplant status
3.6
9.6
41
114
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.4
9.6
78
326
R33
ICD-10 Finland
Retention of urine
1.4
9.5
401
2858
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
5.0
9.5
29
58
7803A
ICD-9 Finland
General symptoms, Convulsions
3.8
9.5
38
100
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.2
9.4
1727
15123
PA2JT
NOMESCO Finland
Very extensive embolisation of arterio-venous malformation of the brain
100.2
9.4
10
*
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
1.8
9.4
168
967
N03AX23
ATC
brivaracetam; systemic
30.0
9.4
12
*
43599
ICD-8 Finland
Transient cerebral ischaemia, Without mention of hypertension
+∞
9.4
9
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
4.3
9.4
33
77
Z50.1
ICD-10 Finland
Other physical therapy
1.7
9.4
199
1208
N74
ICPC
Malignant neoplasm nervous system
21.7
9.3
13
6
I60.4
ICD-10 Finland
Subarachnoid haemorrhage from basilar artery
9.5
9.2
18
19
U04
ICPC
Incontinence urine
1.7
9.2
189
1137
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
5.7
9.2
25
44
X58
ICD-10 Finland
Exposure to other specified factors
1.4
9.1
395
2829
G30.8
ICD-10 Finland
Other Alzheimer disease
1.9
9.1
121
630
I95.1
ICD-10 Finland
Orthostatic hypotension
1.8
9.1
162
936
R13
ICD-10 Finland
Dysphagia
1.6
9.1
235
1504
W17
ICD-10 Finland
Other fall from one level to another
1.8
9.1
141
778
N03AX15
ATC
zonisamide; oral
11.5
9.0
16
14
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
11.5
9.0
16
14
AAF15
NOMESCO Finland
Ventriculoatrial shunt
5.9
9.0
24
41
Z43.0
ICD-10 Finland
Attention to tracheostomy
9.0
9.0
18
20
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
3.5
9.0
40
115
ZXD00
NOMESCO Finland
Emergency procedure
1.9
8.9
124
656
AA1AA
NOMESCO Finland
Head X-ray examination
3.2
8.9
44
137
R1250
NOMESCO Finland
Evaluation of functional capability
2.4
8.9
74
313
N02BE01
ATC
paracetamol; systemic, rectal
1.2
8.9
3454
32510
G46.3*I67.9
ICD-10 Finland
Brain stem stroke syndrome (I60-I67+)
7.4
8.9
20
27
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
6.1
8.9
23
38
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
5.2
8.9
26
50
G45
ICD-10 Finland
Transient cerebral ischaemic attacks and related syndromes
5.7
8.9
24
42
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.2
8.9
9
438
A41.9
ICD-10 Finland
Sepsis, unspecified
1.7
8.7
162
944
RP120
NOMESCO Finland
NA
50.0
8.7
10
*
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
4.1
8.6
32
79
H3603, E103
ICD-10 Finland
NA
4.1
8.6
32
79
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
3.2
8.6
43
136
G91.8
ICD-10 Finland
Other hydrocephalus
11.6
8.6
15
13
PA6AM
NOMESCO Finland
Simple MRI examination of neck vasculature with 3 Tesla magnet
16.3
8.5
13
8
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.8
8.5
915
10909
W06
ICD-10 Finland
Fall involving bed
3.0
8.5
47
159
G94.2
ICD-10 Finland
Hydrocephalus in other diseases classified elsewhere
27.5
8.5
11
*
Z3229
NOMESCO Finland
Other healthcare associate professional
1.4
8.4
338
2385
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
3.2
8.4
41
127
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
3.3
8.4
39
117
RL130
NOMESCO Finland
NA
7.8
8.3
18
23
R01AD12
ATC
fluticasone furoate; nasal
0.7
8.3
430
5615
4349A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral artery occlusion, unspecified[OCCL/STENOS ARTER.CEREBRALES NUD CUM INFARCTU CEREB]
+∞
8.3
8
*
4331A
ICD-9 Finland
Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS CUM INFARCTU CEREBRI]
+∞
8.3
8
*
PA2CD
NOMESCO Finland
Very extensive CT angiography of brain arteries
+∞
8.3
8
*
C08DB01
ATC
diltiazem; oral
1.5
8.3
298
2055
Z02.7
ICD-10 Finland
Issue of medical certificate
1.6
8.3
203
1281
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
8.5
8.3
17
20
4373A
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Cerebral aneurysm, nonruptured
8.5
8.3
17
20
SPAT1251
SPAT
Organisation of medication
1.7
8.2
163
972
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.4
8.2
337
2391
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.1
8.2
93
456
E87.6
ICD-10 Finland
Hypokalaemia
1.9
8.2
115
614
N03AE01
ATC
clonazepam; systemic
1.6
8.2
184
1138
RS222
NOMESCO Finland
NA
2.7
8.2
54
205
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.4
8.2
451
3378
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
8.1
8.1
17
21
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
2.6
8.0
56
218
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
3.0
8.0
43
143
WW805
NOMESCO Finland
Transfer from treating institution to lower-Level care, accompanied by paramedic/nurse
22.0
8.0
11
5
I60
ICD-10 Finland
Subarachnoid haemorrhage
22.0
8.0
11
5
C02CA01
ATC
prazosin; oral
2.0
8.0
96
486
R4120
SPAT
NA
7.2
7.9
18
25
3451A
ICD-9 Finland
Epilepsy, Generalised convulsive epilepsy
7.2
7.9
18
25
J01EA01
ATC
trimethoprim; systemic
1.3
7.9
934
7767
K99
ICPC
Cardiovascular disease other
1.9
7.9
116
629
N03AX16
ATC
pregabalin; oral
1.3
7.9
782
6365
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
2.0
7.9
99
507
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
2.8
7.9
48
174
S00.0
ICD-10 Finland
Superficial injury of scalp
2.1
7.8
85
409
N06AX16
ATC
venlafaxine; oral
1.4
7.8
309
2177
R74
ICPC
Upper respiratory infection acute
0.7
7.8
368
4872
G40.51
ICD-10 Finland
Epileptic seizures related to alcohol
10.8
7.8
14
13
S70.0
ICD-10 Finland
Contusion of hip
1.7
7.8
146
856
Z51.5
ICD-10 Finland
Palliative care
1.5
7.8
267
1829
PA2CG
NOMESCO Finland
Extensive MRI examination of vessels in the head with high intensity magnet
9.4
7.8
15
16
K59.09
ICD-10 Finland
Constipation, unspecified
1.5
7.7
225
1482
SPAT1240
SPAT
Therapeutic discussion
1.6
7.7
213
1388
F05.8
ICD-10 Finland
Other delirium
3.1
7.7
39
125
G81
ICD-10 Finland
Hemiplegia
45.0
7.7
9
*
43090
ICD-8 Finland
Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata
5.0
7.7
23
46
F10.20
ICD-10 Finland
Alcohol dependence currently independent
2.4
7.7
60
248
A12AA04
ATC
calcium carbonate; oral
2.3
7.7
66
287
RS230
NOMESCO Finland
NA
4.6
7.7
25
55
103
Kela drug reimbursment
Diabetes, insulin-treated
1.2
7.6
1125
9588
R51
ICD-10 Finland
Headache
1.8
7.6
119
661
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
7.6
158
956
XF600
NOMESCO Finland
Bloodpressure measurement
1.5
7.6
225
1494
2132
FHL
Ventricular operators sunt
11.8
7.6
13
11
TFC25
NOMESCO Finland
Transseptal catheterisation of left atrium or ventricle
2.9
7.6
44
154
N05CF01
ATC
zopiclone; oral
1.2
7.5
1335
11591
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
1.9
7.5
105
562
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
3.8
7.4
29
76
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
3.7
7.4
30
81
A11CC03
ATC
alfacalcidol; systemic
2.0
7.4
91
462
G44.2
ICD-10 Finland
Tension-type headache
1.4
7.4
324
2328
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.8
7.3
754
9049
C09CA06
ATC
candesartan; oral
1.3
7.3
697
5646
43191
ICD-8 Finland
Cerebral haemorrhage, Subduralis non traumatica, hypertonia non indicata
+∞
7.3
7
*
AAK85
NOMESCO Finland
Replantation of previously excised part of skull cap
+∞
7.3
7
*
ZX120
NOMESCO Finland
Intravenous
1.4
7.3
321
2312
Z49.1
ICD-10 Finland
Extracorporeal dialysis
2.4
7.3
55
226
A10AE05
ATC
insulin detemir; parenteral
1.6
7.3
186
1193
N05BA04
ATC
oxazepam; oral
1.2
7.2
869
7236
SPAT1276
SPAT
Outlining of treatment with patient or their family members
1.9
7.2
96
502
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.3
7.2
34
104
PAN14
NOMESCO Finland
Plastic repair of arteries internal carotid artery
6.2
7.2
18
29
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.7
7.2
308
4134
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.7
7.2
142
847
RS312
NOMESCO Finland
NA
20.0
7.1
10
5
G41.1
ICD-10 Finland
Petit mal status epilepticus
20.0
7.1
10
5
N05AD01
ATC
haloperidol; systemic
1.7
7.1
142
853
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
1.9
7.1
103
557
SPAT1139
SPAT
Nutrition survey
1.8
7.1
122
699
N30.9
ICD-10 Finland
Cystitis, unspecified
1.5
7.1
198
1296
S82
ICPC
Naevus/mole
0.7
7.1
187
2721
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
5.3
7.1
20
38
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
2.8
7.0
42
151
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.5
7.0
224
1515
N01
ICPC
Headache
1.5
6.9
200
1322
V03AE02
ATC
sevelamer; oral
4.0
6.9
25
62
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.2
6.8
66
304
F21
ICPC
NA
2.5
6.8
49
196
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.3
6.8
700
5721
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
3.1
6.8
35
115
C07AB03
ATC
atenolol; systemic
1.4
6.8
281
2001
AA9PW
NOMESCO Finland
NA
40.1
6.8
8
*
G93.6
ICD-10 Finland
Cerebral oedema
40.1
6.8
8
*
B01AB10
ATC
tinzaparin; parenteral
1.5
6.7
221
1499
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
3.1
6.7
34
110
G81.0
ICD-10 Finland
Flaccid hemiplegia
16.7
6.7
10
6
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.6
6.7
44
167
A86
ICD-10 Finland
Unspecified viral encephalitis
4.3
6.7
23
54
SPAT1042
SPAT
Guidance concerning balance maintenance
3.4
6.7
30
89
ZY000
NOMESCO Finland
Hospital inpatient
3.5
6.7
29
84
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.4
6.6
51
212
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
3.1
6.6
33
106
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
5.1
6.6
19
37
L82
ICD-10 Finland
Seborrhoeic keratosis
0.7
6.6
316
4167
ZXF05
NOMESCO Finland
Interruption of procedure for other patient related reason
4.0
6.6
24
60
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.3
6.5
506
3988
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.8
6.5
39
141
N99
ICPC
Neurological disease other
2.5
6.5
46
182
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.2
6.5
59
268
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
6.2
6.4
16
26
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
3.8
6.4
25
66
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
4.5
6.4
21
47
2213
FHL
Hematoma removal, intracerebral or cerebral palsy reversion
69.9
6.4
7
*
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
2.5
6.4
47
192
N06AX21
ATC
duloxetine; oral
1.4
6.4
273
1957
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.0
6.4
34
115
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
6.4
146
911
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
3.2
6.4
30
93
A10BB01
ATC
glibenclamide; oral
1.4
6.3
249
1753
WX408
NOMESCO Finland
General anesthesy, balanced
1.2
6.3
886
7489
F07.9
ICD-10 Finland
Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction
8.1
6.3
13
16
H36.01
ICD-10 Finland
Diabetic maculopathy
2.5
6.3
45
179
S00.9
ICD-10 Finland
Superficial injury of head, part unspecified
2.7
6.3
39
145
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
11.0
6.3
11
10
F01.8
ICD-10 Finland
Other vascular dementia
11.0
6.3
11
10
N06DX01
ATC
memantine; oral
1.4
6.3
348
2609
N06DA04
ATC
galantamine; oral
1.8
6.3
104
592
JN5BD
NOMESCO Finland
Head and body CT examination for trauma
3.2
6.3
30
94
4301A
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACH.POST MALFORMAT.ARTERIOVENOSAM]
+∞
6.2
6
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.4
6.2
51
218
D68.8
ICD-10 Finland
Other specified coagulation defects
3.1
6.2
31
100
J69.1
ICD-10 Finland
Pneumonitis due to oils and essences
26.7
6.2
8
*
L57.0
ICD-10 Finland
Actinic keratosis
0.7
6.2
251
3398
ZXC95
NOMESCO Finland
Use of surgical navigator
2.7
6.2
38
140
A10AA01
ATC
NA
2.0
6.2
73
368
M05BB03
ATC
alendronic acid and colecalciferol; oral
1.8
6.2
101
572
Z08
ICPC
Social welfare problem
2.8
6.2
36
128
-2
ICPC
NA
2.8
6.1
37
135
A10AA02
ATC
NA
1.7
6.1
124
750
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
1.9
6.1
83
439
Z72.1
ICD-10 Finland
Alcohol use
2.6
6.1
41
159
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.6
6.1
153
975
C08CA13
ATC
lercanidipine; oral
1.3
6.1
503
3997
3313A
ICD-9 Finland
Other cerebral degenerations, Communicating hydrocephalus
7.7
6.1
13
17
K92.0
ICD-10 Finland
Haematemesis
1.8
6.1
104
595
B18.2
ICD-10 Finland
Chronic viral hepatitis C
3.4
6.1
27
80
V03AA01
ATC
NA
2.2
6.1
54
243
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
6.1
541
4343
N03AX11
ATC
topiramate; oral
2.4
6.0
45
186
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.4
6.0
294
2160
N02AA05
ATC
oxycodone; systemic
1.3
6.0
619
5056
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1653
5395
4.00
307.65
2.5
1.9
s
29.4
30.4
8.43
1614
5203
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2314
11382
2.84
287.92
2.8
2.0
u/l
236.4
247.0
0.18
2232
10429
(3036489) Thrombin time
483
977
5.34
227.35
2.4
2.0
s
21.3
21.9
1.10
450
877
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
124
100
12.67
126.69
2.5
2.2
umol/l
53.5
54.6
0.12
94
69
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
184
260
7.29
123.60
2.9
1.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
217
395
5.68
113.69
3.7
4.6
umol/l
340.3
335.5
0.16
182
340
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1245
6632
2.15
109.08
3.6
3.0
mmol/l
0.8
0.8
0.33
1160
6090
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
312
807
4.04
106.74
3.1
2.3
%
192.9
203.9
1.21
307
761
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
149
204
7.48
102.88
2.0
2.0
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
335
936
3.75
102.70
3.2
2.3
g/l
3.5
3.6
0.32
328
891
(3051593) INR in Capillary blood by Coagulation assay
117
134
8.90
93.65
2.4
24.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
2512
17793
1.78
89.36
11.4
10.5
inr
1.5
1.3
0.49
701
4763
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
302
872
3.61
88.01
2.9
2.1
%
92.0
87.4
2.62
291
827
(3044290) Cell count panel - Cerebral spinal fluid
225
557
4.17
81.50
2.7
1.3
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
232
603
3.98
78.62
2.6
1.4
e6/l
21359.7
733.0
0.69
183
486
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
232
604
3.97
78.44
2.6
1.3
e6/l
53.0
25.2
0.79
182
463
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
105
136
7.85
76.02
3.3
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
951
5195
2.01
74.67
10.5
6.3
mmol/l
1.3
1.1
0.99
737
3962
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
949
5202
2.00
73.70
10.6
6.3
kpa
5.1
5.1
0.03
896
4899
(3027801) Oxygen [Partial pressure] in Arterial blood
948
5200
2.00
73.46
10.6
6.3
kpa
12.4
11.9
2.48
898
4891
(3003458) Phosphate [Moles/volume] in Serum or Plasma
989
5531
1.97
72.38
6.4
5.4
mmol/l
1.0
1.0
3.20
917
5030
(3033658) Prothrombin time (PT) actual/Normal
1491
9557
1.78
70.66
5.6
3.9
%
82.1
84.4
2.90
1456
9315
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
76
71
10.84
70.51
1.1
1.2
%
83.7
83.7
0.00
33
40
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
76
73
10.55
69.18
1.1
1.4
%
85.5
81.8
0.22
34
43
(3023368) Bacteria identified in Blood by Culture
1863
12898
1.69
65.90
4.9
4.2
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
87
110
8.02
64.27
3.2
2.5
umol/l
31.5
29.0
0.84
70
77
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
59
44
13.55
63.00
2.2
3.6
umol/l
45.3
38.9
0.78
52
36
(3013826) Glucose [Moles/volume] in Serum or Plasma
3013
23841
1.61
60.52
8.1
4.6
mmol/l
7.1
6.9
4.37
2892
22300
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
58
46
12.73
59.72
1.2
1.2
%
73.4
77.5
0.18
12
16
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
228
721
3.26
57.41
2.2
1.3
mg/l
829.8
588.2
1.47
215
670
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
57
47
12.25
57.30
1.2
1.1
%
79.1
80.9
0.07
12
17
(3023183) Ammonium ion [Moles/volume] in Plasma
238
774
3.17
57.21
2.8
2.4
umol/l
31.8
35.4
1.26
200
629
(3020191) Ethanol [Moles/volume] in Serum or Plasma
114
218
5.32
56.53
1.6
1.3
promille
1.1
1.1
0.11
77
171
(3016502) Oxygen saturation in Arterial blood
812
4641
1.89
54.26
11.6
6.6
%
95.8
95.2
1.63
776
4440
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
204
629
3.33
53.51
2.0
1.3
mmol/l
3.9
3.8
0.43
189
577
(3002173) Hemoglobin [Mass/volume] in Arterial blood
744
4186
1.90
52.02
12.3
7.0
g/l
121.2
120.1
0.72
722
4024
(3016018) Differential panel - Cerebral spinal fluid
120
279
4.38
47.17
3.2
1.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
894
5540
1.74
44.93
9.2
6.3
mmol/l
104.6
104.3
0.93
869
5403
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
352
1584
2.31
44.46
3.6
2.5
u/ml
0.3
0.3
0.45
208
879
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2454
19332
1.50
44.30
9.0
5.8
mmol/l
1.2
1.2
13.64
2247
17225
(3023410) Appearance of Cerebral spinal fluid
109
248
4.47
44.05
3.2
1.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
690
4054
1.81
41.40
8.7
6.2
mmol/l
9.4
11.5
11.01
646
3806
(3026008) Bacteria identified in Urine by Culture
1796
13419
1.51
40.92
3.9
3.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1118
7508
1.62
40.91
2.1
1.8
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
458
2372
2.02
40.32
12.1
8.1
mmol/l
24.5
24.3
0.46
429
2161
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
476
2504
1.99
40.09
11.0
6.7
mmol/l
24.4
24.8
1.45
468
2484
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2625
21378
1.45
37.61
9.7
6.5
mmol/l
1.2
1.2
6.59
2232
17782
(3003181) Sodium [Moles/volume] in Urine
200
751
2.73
37.08
1.5
1.3
mmol/l
79.4
61.7
5.08
164
598
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
814
5191
1.67
36.10
2.0
1.7
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
319
1503
2.19
35.96
2.5
2.1
ug/l
447.8
713.7
0.87
305
1426
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2106
16590
1.45
35.25
4.9
4.0
ng/l
86.8
102.3
0.16
1777
12599
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
803
5162
1.65
34.39
2.0
1.8
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
509
2877
1.85
34.34
11.8
6.2
mmol/l
24.8
24.5
0.86
478
2674
(3019060) Gas panel - Arterial blood
536
3091
1.82
33.87
7.9
4.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
672
4148
1.71
33.51
2.4
2.3
ug/l
6.5
6.6
0.10
571
3463
(3022217) INR in Platelet poor plasma by Coagulation assay
962
6506
1.58
33.38
26.9
29.6
inr
1.6
1.5
0.69
123
859
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
89
216
4.17
33.15
2.2
1.2
mmol/l
2.8
2.1
2.31
74
199
(3044640) Blood type and Crossmatch panel - Blood
1675
12769
1.46
32.73
2.8
2.5
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
284
1357
2.15
30.87
7.2
3.8
mmol/l
3.8
3.9
1.13
264
1261
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
467
2658
1.83
30.70
1.6
1.5
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
318
1597
2.05
30.32
6.6
3.6
mmol/l
1.4
1.4
0.10
311
1570
(3014111) Lactate [Moles/volume] in Serum or Plasma
628
3924
1.68
29.72
10.2
6.0
mmol/l
1.4
1.4
0.03
597
3747
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1167
8431
1.49
29.44
4.5
4.0
ng/l
284.9
575.3
1.54
1024
7274
(3000991) Gas panel - Venous blood
592
3711
1.67
27.57
12.2
7.2
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
145
557
2.65
25.78
6.4
6.0
mg/l
11.3
12.2
1.17
130
506
(3002032) Base excess in Venous blood by calculation
656
4330
1.59
24.66
4.8
3.5
mmol/l
2.0
1.9
0.21
556
3473
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1276
9703
1.41
23.77
2.7
2.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
754
10609
0.66
23.44
3.3
3.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
103
351
2.97
22.96
1.4
1.2
u/ml
4.3
3.5
0.30
57
150
(3018418) pH of Serum or Plasma
1591
12628
1.37
22.75
4.8
4.0
ph
7.4
7.4
0.43
293
2352
(3021447) Carbon dioxide [Partial pressure] in Venous blood
648
4351
1.56
22.50
4.8
3.5
kpa
5.9
5.8
0.55
630
4202
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
104
366
2.88
21.90
1.4
1.2
u/ml
2.4
2.3
0.01
45
116
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
60
149
4.06
21.78
1.1
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3284
36258
0.75
21.21
4.8
5.0
mmol/l
6.2
6.1
1.75
2930
31980
(3008295) Osmolality of Serum or Plasma
110
406
2.74
21.20
1.5
1.3
mosm/kgh2o
281.6
276.4
1.41
87
297
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3218
35536
0.76
20.06
4.5
4.5
mmol/l
4.2
4.5
42.88
2953
31775
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3340
36689
0.76
19.98
5.1
5.1
mmol/l
2.4
2.6
35.59
3049
32648
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3179
35147
0.76
19.86
4.5
4.5
mmol/l
1.4
1.4
12.84
2907
31170
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
53
129
4.14
19.78
2.0
1.2
%
53.8
61.7
0.35
16
18
(3026782) Osmolality of Urine
1145
8783
1.39
19.71
3.4
2.9
mosm/kgh2o
547.5
555.0
0.59
1001
7434
(3024354) Oxygen [Partial pressure] in Venous blood
538
3564
1.57
19.71
4.1
2.9
kpa
4.8
4.4
2.82
522
3432
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
384
2372
1.67
18.73
14.5
8.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3164
34896
0.77
18.62
23.1
16.0
ml/min/173m2
75.4
72.8
8.29
2720
28735
(4306422)
90
326
2.79
18.03
1.2
1.2
—
—
—
0
0
(3020891) Body temperature
308
1820
1.73
17.70
7.9
4.3
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
47
114
4.15
17.65
33.3
26.1
ug/l
109.2
120.8
0.59
41
97
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2125
18092
1.29
17.35
4.8
4.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
90
334
2.72
17.24
1.2
1.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
430
2790
1.59
17.18
4.0
3.1
g/l
126.6
127.0
0.13
423
2719
(3031040) Bacteria [#/volume] in Urine by Automated count
2992
26712
1.28
16.29
6.1
4.9
e6/l
2337.3
2282.0
0.02
58
460
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
479
3234
1.53
16.02
1.8
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1398
11371
1.31
15.75
4.1
3.1
u/l
36.5
38.3
0.35
1305
10662
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
49
135
3.65
15.47
1.4
1.1
—
—
—
0
0
(4198724)
31
60
5.19
15.29
1.6
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
54
161
3.38
15.15
1.1
1.1
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
15
12
12.53
15.13
1.3
1.0
s
35.5
38.4
0.37
15
12
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
20
25
8.02
14.88
1.0
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
241
1399
1.76
14.77
1.3
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1252
15246
0.77
14.65
2.3
2.2
—
—
—
0
0
(4268621)
68
238
2.88
14.59
2.4
2.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
74
1798
0.40
14.28
1.6
1.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1196
9644
1.31
14.11
1.8
1.8
nmol/l
1171.1
1161.9
0.12
920
7045
(3009343) pH of Capillary blood
429
2910
1.52
14.01
4.3
3.7
ph
7.4
7.4
0.30
57
353
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
417
2812
1.52
14.00
4.2
3.6
mmol/l
1.9
2.0
0.15
291
2021
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1028
8123
1.33
14.00
2.5
1.6
mg/l
1.6
1.5
0.42
844
6308
(3027273) Bicarbonate [Moles/volume] in Venous blood
357
2329
1.57
13.91
3.9
3.3
mmol/l
25.4
25.2
0.62
349
2257
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
432
2950
1.51
13.66
4.3
3.7
kpa
5.2
5.2
0.02
395
2676
(3036481) Cortisol [Moles/volume] in Serum or Plasma
458
3166
1.49
13.65
2.2
2.1
nmol/l
382.8
380.5
0.08
417
2870
(3047181) Lactate [Moles/volume] in Blood
228
1335
1.74
13.57
10.1
5.6
mmol/l
1.5
1.4
0.77
198
1174
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3701
39461
0.79
12.77
13.3
10.7
u/l
26.0
25.2
0.50
3542
37506
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
34
83
4.12
12.73
1.4
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
27
55
4.93
12.60
1.1
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3128
33949
0.81
12.52
4.2
4.0
mmol/l
1.3
1.3
0.03
2843
29796
(3016038) Potassium [Moles/volume] in Urine
71
276
2.59
12.52
1.2
1.1
mmol/l
32.3
35.7
0.62
62
218
(3002582) Erythrocytes [#/volume] in Urine
1554
13137
1.26
12.30
4.2
3.4
e6/l
69.7
114.4
1.62
1279
10221
(3007853) Bacteria identified in Skin by Aerobe culture
631
4716
1.38
12.23
2.0
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3218
34787
0.81
12.22
6.4
6.4
mmol/mol
41.5
40.9
2.21
2923
31275
(3010813) Leukocytes [#/volume] in Blood
3859
40876
0.79
12.03
35.2
24.4
e9/l
7.3
6.9
14.81
3722
39285
(3026361) Erythrocytes [#/volume] in Blood
3858
40865
0.79
12.01
35.2
24.4
e12/l
4.3
4.4
29.91
3717
39279
(3024731) MCV [Entitic volume]
3858
40863
0.79
11.99
35.1
24.3
fl
91.7
91.6
0.48
3775
39947
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
736
9427
0.75
11.99
1.7
1.6
mmol/l
1.4
1.3
0.77
642
7743
(3035941) MCH [Entitic mass]
3858
40862
0.79
11.98
35.1
24.3
pg
30.5
30.4
0.76
3774
39946
(3000963) Hemoglobin [Mass/volume] in Blood
3859
40871
0.79
11.98
35.5
24.5
g/l
129.7
133.1
34.24
3779
39967
(3000850) Epithelial cells [#/volume] in Urine
1134
9253
1.29
11.96
3.3
2.7
e6/l
5.3
4.8
0.62
1035
8072
(3007461) Platelets [#/volume] in Blood
3858
40855
0.79
11.91
35.2
24.4
e9/l
238.4
239.6
0.49
3734
39433
(3014271) Vancomycin [Susceptibility]
74
301
2.48
11.90
3.1
3.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
1371
11464
1.26
11.82
4.0
3.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
40
1168
0.34
11.63
1.4
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
2115
18588
1.23
11.55
5.9
4.6
g/l
33.5
34.5
14.16
1940
16984
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
321
2139
1.53
11.40
5.5
3.6
mmol/l
24.3
24.1
0.47
303
1902
(3026250) Tacrolimus [Mass/volume] in Blood
36
100
3.62
11.31
37.0
31.9
ug/l
7.0
7.2
0.13
31
90
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
787
9900
0.76
11.17
2.9
3.2
ug/l
0.9
0.8
0.57
567
7029
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
42
131
3.22
11.05
1.7
1.6
umol/l
55.6
103.2
1.37
16
79
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
301
2003
1.53
10.76
2.4
1.9
ug/l
3.2
2.5
0.21
247
1729
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
430
3078
1.43
10.67
2.0
1.7
%
1.8
1.5
3.65
356
2599
(3015235) Bicarbonate [Moles/volume] in Capillary blood
203
1236
1.67
10.54
3.6
3.1
mmol/l
24.6
25.0
0.80
182
1065
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
286
1891
1.54
10.54
8.3
4.7
%
1.6
1.6
0.47
268
1768
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
19
33
5.77
10.52
1.0
1.3
mmol/l
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
204
1246
1.66
10.47
3.8
3.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
29
75
3.88
10.10
4.7
4.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
29
75
3.88
10.10
1.3
1.3
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
280
1862
1.53
10.06
8.5
4.7
%
0.9
0.9
0.72
262
1740
(3030467) Casts [#/volume] in Urine by Automated count
1403
11951
1.24
9.96
4.1
3.3
e6/l
0.5
0.5
0.05
1148
9108
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
32
90
3.57
9.90
1.5
1.3
%
18.8
28.0
0.39
17
15
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1508
17377
0.81
9.90
4.6
5.4
ug/l
7.7
4.4
0.44
1328
15328
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
86
407
2.13
9.80
1.4
1.4
pmol/l
266.2
263.1
0.03
64
317
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
400
2871
1.43
9.78
1.9
1.7
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
67
287
2.35
9.70
1.0
1.1
—
0.8
—
0
5
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
14
19
7.38
9.69
1.0
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
90
436
2.08
9.66
1.3
1.4
mu/l
53.6
57.5
0.07
81
382
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
21
45
4.68
9.28
1.2
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1694
14805
1.21
9.20
4.9
3.9
e6/l
108.3
124.8
0.41
1335
10838
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
510
3879
1.35
8.78
2.5
2.0
g/l
0.2
0.2
0.06
474
3553
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
840
6837
1.27
8.77
3.6
3.1
e6/l
2.0
2.2
0.29
503
3832
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1188
13887
0.81
8.71
4.1
4.6
%
23.1
22.2
1.09
569
7318
(3028626) Oxygen [Partial pressure] in Capillary blood
180
1119
1.63
8.68
4.2
2.9
kpa
8.2
7.9
1.66
166
1033
(21494755) Public health laboratory ask at order entry panel
80
1559
0.51
8.63
1.3
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
39
136
2.88
8.56
2.6
2.5
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
159
961
1.67
8.56
12.5
6.3
mmol/l
104.7
105.0
0.21
143
851
(3039000) Anion gap in Blood
159
961
1.67
8.56
12.5
6.3
mmol/l
11.3
11.4
0.13
143
851
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
8
16.29
8.54
1.2
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2399
21763
1.19
8.43
4.3
3.1
u/l
72.3
56.5
5.66
2245
19516
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
24
64
3.76
8.05
1.2
1.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
736
5955
1.27
8.03
2.3
1.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
54
232
2.34
7.84
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
60
273
2.21
7.63
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
260
1806
1.46
7.62
2.0
1.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
54
237
2.29
7.49
1.2
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2335
21271
1.17
7.47
7.2
5.9
umol/l
12.2
12.4
0.38
2212
20066
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
55
244
2.27
7.44
2.2
2.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
873
7274
1.24
7.35
3.3
2.9
e6/l
1.1
1.2
0.15
536
4235
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
165
1050
1.59
7.29
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
165
1050
1.59
7.29
1.4
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
556
4396
1.30
7.26
3.7
2.6
umol/l
10.4
9.6
0.29
487
3786
(3024932) HLA-DR beta [Type]
26
79
3.30
7.22
1.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
291
2088
1.42
7.18
4.4
3.8
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
126
752
1.69
7.18
2.1
1.9
mmol/l
2.0
1.7
1.53
111
735
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
274
1947
1.43
7.14
2.2
1.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
79
413
1.93
6.98
2.7
2.9
—
—
—
0
0
(3024471) HLA-A [Type]
26
81
3.22
6.95
1.0
1.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
3061
32573
0.86
6.93
28.0
18.1
%
37.1
38.6
10.16
1849
20337
(3028707) Methadone [Presence] in Urine by Screen method
46
195
2.37
6.92
3.3
2.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
54
247
2.20
6.82
2.4
2.3
—
—
—
0
0
(3010421) pH of Blood
180
1188
1.53
6.80
4.8
4.6
ph
7.4
7.4
0.78
151
1019
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
18
44
4.10
6.80
1.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
22
651
0.34
6.74
1.6
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1061
9094
1.21
6.72
4.3
3.8
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
26
83
3.14
6.70
1.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
36
851
0.42
6.69
1.5
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
310
4155
0.73
6.64
1.3
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
51
231
2.22
6.61
1.1
1.1
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
161
1044
1.56
6.60
4.7
4.8
kpa
8.2
8.3
0.31
152
1023
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
26
84
3.10
6.57
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
27
90
3.01
6.48
1.0
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
143
908
1.59
6.43
4.3
2.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
113
678
1.68
6.36
7.3
4.7
iu/ml
1218.0
4198.4
0.53
22
96
(3012501) Base excess in Blood by calculation
159
1038
1.55
6.34
4.7
4.8
mmol/l
2.5
2.7
0.49
105
703
(3013290) Carbon dioxide [Partial pressure] in Blood
159
1039
1.55
6.32
4.7
4.8
kpa
5.0
5.0
0.02
150
1019
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
38
4.22
6.27
3.7
5.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
401
5130
0.76
6.21
1.2
1.2
u/ml
29.0
14.0
0.52
137
1784
(3032352) Blasts [#/volume] in Cerebral spinal fluid
14
30
4.68
6.20
5.8
2.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
86
482
1.80
6.16
1.4
1.2
u/ml
281.3
290.8
0.12
63
292
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
279
3753
0.73
6.12
1.3
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
90
513
1.77
6.10
1.6
1.4
u/ml
136.3
122.3
0.19
17
108
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
16
39
4.11
6.08
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
97
1609
0.60
6.08
1.2
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
389
3015
1.31
5.91
1.8
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
99
587
1.70
5.85
1.7
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
985
8485
1.20
5.84
5.2
4.4
kg/l
1.0
1.0
1.03
174
1334
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
17
45
3.79
5.80
1.0
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
74
404
1.84
5.79
1.7
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1424
12673
1.17
5.73
3.1
2.5
u/l
59.4
58.9
0.09
1329
11603
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
21
65
3.24
5.71
1.2
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
26
92
2.83
5.66
1.4
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
2902
27219
1.15
5.57
5.5
4.6
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
24
82
2.93
5.56
1.0
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
90
528
1.72
5.55
1.4
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
566
4642
1.25
5.46
5.0
3.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
141
929
1.53
5.45
3.6
2.8
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
29
112
2.60
5.37
1.9
1.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
242
1775
1.38
5.33
4.8
4.1
mmol/l
24.7
24.8
0.13
221
1598
(40761511) CBC panel - Blood by Automated count
3668
38240
0.87
5.33
23.6
16.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
25
90
2.79
5.29
1.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
68
374
1.83
5.24
1.8
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
410
3254
1.28
5.23
1.8
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
151
1020
1.49
5.21
2.8
2.6
%
16.8
15.7
2.03
77
527
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
240
3219
0.73
5.20
1.3
1.3
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
14
35
4.01
5.16
1.0
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
451
3629
1.27
5.15
3.9
3.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
425
5268
0.79
5.11
1.3
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3198
33597
0.88
4.99
4.7
4.6
mu/l
2.0
2.1
2.18
2898
29710
(1616796) Gas panel - Central venous blood
154
1055
1.47
4.97
3.9
3.9
—
—
—
0
0
(3002256) Pathology report gross observation
427
5267
0.79
4.93
1.4
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
445
3599
1.26
4.87
2.7
2.4
u/l
37.6
51.3
0.48
376
3052
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
18
57
3.16
4.75
12.8
12.1
mmol/l
5.6
5.3
0.12
18
57
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
142
967
1.48
4.74
1.9
1.6
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
21
74
2.84
4.64
1.0
1.1
—
—
—
0
0
(3025315) Body weight
12
29
4.14
4.62
6.3
4.9
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
20
69
2.90
4.59
1.2
1.1
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
7
5
14.01
4.57
1.0
1.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
30
128
2.35
4.56
1.0
1.1
u/l
1.1
1.2
0.38
14
65
(3013139) Helicobacter pylori Ag [Presence] in Stool
168
2331
0.71
4.53
1.2
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
527
4381
1.23
4.50
3.6
3.0
ng/l
263.7
255.4
0.16
472
4000
(3015377) Calcium [Moles/volume] in Serum or Plasma
1570
14284
1.14
4.46
3.5
3.3
mmol/l
2.3
2.4
1.01
1336
12112
(3006922) Hepatitis E virus Ab [Presence] in Serum
38
181
2.11
4.46
1.1
1.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
146
1014
1.45
4.44
1.9
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
151
1061
1.44
4.32
2.3
2.2
g/l
132.5
126.7
1.69
106
769
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
45
3.34
4.31
1.0
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
453
5468
0.81
4.29
1.2
1.3
iu/ml
49.5
39.1
0.45
125
1683
(3044889) 12 lead EKG panel
2565
27190
0.89
4.28
4.4
4.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
12
31
3.88
4.25
2.0
2.0
umol/l
18.7
15.6
0.31
12
31
(3007566) Smooth muscle Ab [Titer] in Serum
124
842
1.48
4.24
1.3
1.2
titre
71.3
100.3
—
8
65
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
35
166
2.12
4.17
1.1
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
20
73
2.75
4.17
1.2
1.1
—
—
—
0
0
(44790047)
71
426
1.68
4.13
2.1
1.4
—
—
—
0
0
(44790049)
71
426
1.68
4.13
2.1
1.4
—
—
—
0
0
(44790048)
71
426
1.68
4.13
2.1
1.4
—
—
—
0
0
(44806118)
71
426
1.68
4.13
2.1
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2589
27389
0.89
4.09
3.7
3.8
pmol/l
15.0
15.1
0.41
2305
24145
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
49
870
0.56
4.09
1.7
1.6
mg/l
5.2
3.9
0.19
39
630
(3024891) Influenza virus A+B Ag [Presence] in Specimen
135
940
1.45
4.08
1.3
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
70
422
1.67
4.02
1.4
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
27
117
2.31
4.00
1.1
1.2
ratio
1.1
1.1
0.69
12
36
(3023103) Potassium [Moles/volume] in Serum or Plasma
3830
39580
0.88
3.98
30.8
19.9
mmol/l
4.0
4.0
14.18
3725
38309
(3040151) Glucose [Moles/volume] in Capillary blood
89
572
1.57
3.95
14.7
7.0
mmol/l
7.2
7.3
0.20
77
450
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
256
3267
0.77
3.95
1.6
1.6
—
—
—
0
0
(4027681)
29
131
2.22
3.91
1.3
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1469
13406
1.13
3.89
6.7
5.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
1163
10458
1.14
3.87
5.2
4.3
estimate
0.0
0.0
1.28
322
3338
(3000492) Spirometry study
232
2990
0.77
3.86
1.5
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
249
1933
1.30
3.84
1.5
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
32
152
2.11
3.83
1.3
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
93
609
1.54
3.81
1.9
1.9
%
88.5
88.8
0.17
84
604
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
34
166
2.05
3.79
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
34
166
2.05
3.79
1.2
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
75
1171
0.64
3.78
1.3
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
67
407
1.65
3.76
1.4
1.2
nmol/l
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
3828
39510
0.89
3.70
31.0
19.7
mmol/l
139.1
139.6
15.43
3733
38298
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
937
8330
1.15
3.66
3.1
3.1
mmol/l
2.5
2.5
0.04
778
7214
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
11
30
3.67
3.63
1.0
1.1
—
—
—
0
0
(3051671) S100 calcium binding protein B [Mass/volume] in Serum
8
13
6.16
3.50
3.0
2.0
ug/l
0.1
0.1
—
8
13
(40768793) Breast Pathology biopsy report
40
710
0.56
3.40
1.3
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
49
282
1.74
3.38
4.9
2.8
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
15
53
2.83
3.35
1.7
2.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1867
17402
1.11
3.34
6.8
5.7
%
0.6
0.7
4.13
1750
15970
(3044242) Glucose [Moles/volume] in Arterial blood
43
239
1.81
3.33
1.6
2.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
56
336
1.67
3.33
2.8
1.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
614
5333
1.17
3.27
5.0
3.8
u/l
260.3
249.5
0.68
569
4972
(3002385) Erythrocyte distribution width [Ratio]
2845
29757
0.90
3.27
30.4
20.2
%
14.0
13.9
4.36
2775
28968
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
46
264
1.75
3.22
1.1
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
38
206
1.85
3.20
3.0
3.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
2026
19002
1.11
3.18
6.3
5.4
e9/l
0.0
0.0
2.73
1752
16026
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
78
514
1.52
3.17
1.1
1.0
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
2013
18878
1.11
3.16
6.3
5.4
e9/l
0.6
0.6
3.07
1737
15898
(3033705) Calcium.ionized [Moles/volume] in Venous blood
98
678
1.45
3.15
2.7
2.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
20
85
2.36
3.14
1.0
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
40
223
1.80
3.09
1.3
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
96
1364
0.70
3.08
1.7
1.7
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
99
690
1.44
3.07
2.7
2.4
mmol/l
4.0
4.1
1.85
99
683
(3035285) Chloride [Moles/volume] in Venous blood
99
690
1.44
3.07
2.7
2.4
mmol/l
105.1
105.5
0.31
99
683
(3045716) Anion gap in Serum or Plasma
36
195
1.85
3.05
2.1
2.0
mmol/l
9.9
9.1
0.59
30
150
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
112
800
1.41
3.04
1.4
1.2
—
—
—
0
0
(4094501)
62
957
0.64
3.04
1.1
1.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
2060
19370
1.10
3.04
6.4
5.5
e9/l
1.7
1.9
2.86
1791
16623
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
85
1230
0.69
3.02
1.6
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
410
4820
0.84
2.99
3.2
4.0
ug/l
21.9
21.4
0.02
345
3994
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
34
185
1.84
2.86
1.3
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
44
259
1.70
2.85
1.2
1.2
titre
115.0
125.0
—
6
46
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
44
259
1.70
2.85
1.2
1.2
titre
280.0
80.0
—
6
7
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1247
11455
1.12
2.85
2.3
2.3
mg/l
3.3
3.1
0.69
1041
9579
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
28
143
1.96
2.84
1.0
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
228
2823
0.80
2.81
2.3
2.1
nmol/l
10.7
12.1
1.53
185
2424
(3006504) Eosinophils/100 leukocytes in Blood
1905
17896
1.10
2.81
6.8
5.7
%
2.7
2.9
2.39
1783
16404
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
26
130
2.00
2.79
1.2
1.1
ng/l
1767.7
607.5
—
10
35
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
14
53
2.65
2.79
1.7
2.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
310
2575
1.22
2.76
2.5
2.7
g/l
11.0
10.7
0.67
279
2318
(3019069) Monocytes/100 leukocytes in Blood
1912
17979
1.10
2.75
7.1
6.0
%
9.1
8.9
1.84
1794
16529
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
30
160
1.88
2.70
1.0
1.1
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
11
37
2.98
2.69
5.5
4.8
ug/min
68.2
71.7
0.03
11
30
(4010399)
213
2642
0.80
2.68
1.5
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
49
303
1.62
2.66
2.4
2.2
%
10.1
10.6
0.38
49
303
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
20
92
2.18
2.66
1.0
1.1
miu/ml
1507.5
1645.3
0.20
20
92
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
99
711
1.40
2.65
1.7
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
2074
19602
1.10
2.65
6.6
5.6
e9/l
0.2
0.2
1.21
1809
16762
(3016879) Cocaine [Presence] in Urine
62
408
1.53
2.60
3.1
2.0
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
33
184
1.80
2.60
1.1
1.1
mg/l
401.7
296.5
1.30
28
156
(3048929) Epstein Barr virus Ab [Presence] in Serum
97
697
1.40
2.60
1.4
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
436
5030
0.85
2.56
4.4
4.6
%
33.8
32.9
0.93
336
3085
(3026493) Urate [Moles/volume] in Serum or Plasma
989
10807
0.90
2.54
3.2
2.8
umol/l
5231.7
6152.8
0.25
845
9108
(3015736) pH of Urine
1595
14922
1.10
2.51
4.2
3.7
—
5.7
—
0
13
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
86
609
1.42
2.51
1.9
1.5
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
19
88
2.16
2.50
1.1
1.5
—
—
—
0
0
(3019977) pH of Arterial blood
45
278
1.62
2.48
1.5
2.3
ph
7.4
7.4
0.24
13
103
(46235355) HIV 1 and 2 tests - Meaningful Use set
437
3783
1.17
2.47
1.8
1.6
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
39
2.82
2.47
1.0
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
11
39
2.82
2.47
1.9
1.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
8
6.25
2.37
3.6
1.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1905
18008
1.09
2.36
6.7
5.6
%
60.7
58.7
9.80
1788
16529
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
72
500
1.45
2.36
2.0
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
65
443
1.47
2.34
3.0
1.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
780
7060
1.12
2.31
3.0
2.5
umol/l
11.5
12.1
1.69
698
6414
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
9
28
3.22
2.30
1.2
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
65
445
1.47
2.30
3.0
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
64
438
1.47
2.27
3.0
2.0
—
—
—
0
0
(4034850)
160
1266
1.27
2.27
12.4
11.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
71
496
1.44
2.27
1.2
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
42
262
1.61
2.25
1.0
1.0
ng/l
47.5
46.8
0.03
22
159
(3008898) HLA-B27 [Presence]
52
774
0.67
2.23
1.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
61
415
1.47
2.23
3.6
3.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
632
5661
1.13
2.23
2.6
2.3
%
1.9
1.8
1.24
543
4898
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
42
263
1.60
2.22
1.0
1.0
ng/l
607.3
677.8
0.44
20
157
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
26
142
1.83
2.22
1.7
2.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
26
142
1.83
2.22
1.7
2.2
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
5
9
5.56
2.21
1.0
1.2
mmol/l
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
86
625
1.38
2.21
1.4
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
101
755
1.34
2.18
2.0
1.6
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
24
3.34
2.17
1.0
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
157
1248
1.27
2.16
2.0
1.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
246
2057
1.21
2.12
1.9
1.9
g/l
1.3
1.4
0.24
212
1828
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
130
1013
1.29
2.10
6.3
2.9
mg/l
1.7
1.7
0.18
120
891
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
87
640
1.36
2.09
1.6
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
39
244
1.60
2.09
2.2
1.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
1930
18332
1.08
2.07
7.0
5.9
%
23.8
26.0
15.62
1803
16736
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
416
3642
1.15
2.07
4.9
3.9
mmol/l
1.2
1.2
1.53
366
3115
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
5
10
5.00
2.07
1.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
9
31
2.91
2.07
1.1
1.2
u/l
15.2
11.9
—
9
31
(3028679) Herpes simplex virus Ab [Presence] in Serum
22
117
1.88
2.05
1.0
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
279
2370
1.19
2.03
1.5
1.6
g/l
1.5
1.5
0.30
229
2011
(3027456) Digoxin [Moles/volume] in Serum or Plasma
153
1223
1.26
2.03
3.1
3.1
nmol/l
0.8
0.8
1.23
110
915
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
41
262
1.57
2.02
1.0
1.0
ng/l
414.0
335.8
0.61
22
162
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
111
853
1.31
2.01
1.7
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
383
3347
1.16
1.97
4.8
3.6
ng/l
117.5
95.6
3.00
313
2801
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
7
21
3.34
1.96
1.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
27
156
1.73
1.95
1.2
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
14
64
2.19
1.94
1.4
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
21
113
1.86
1.91
1.7
2.0
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
57
397
1.44
1.90
1.3
1.2
u/l
63.9
63.0
0.03
41
272
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
47
316
1.49
1.87
1.5
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
12
251
0.48
1.85
1.0
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
285
2448
1.17
1.85
3.4
2.9
e6/l
0.2
0.3
2.96
279
2401
(3017569) Oxygen content in Arterial blood
36
229
1.58
1.84
1.6
2.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
58
409
1.42
1.82
1.4
1.5
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
12
4.17
1.82
1.0
7.0
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
53
368
1.44
1.81
2.0
1.9
—
4.0
—
0
5
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
9
35
2.57
1.80
1.8
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
9
35
2.57
1.80
1.8
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
9
35
2.57
1.80
1.8
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
62
444
1.40
1.79
1.1
1.1
g/l
1.6
1.6
0.54
54
393
(3027944) Amphetamines [Presence] in Urine
61
436
1.40
1.78
3.1
1.8
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
47
321
1.47
1.75
1.5
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
36
232
1.56
1.75
1.3
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
37
240
1.55
1.75
1.7
1.6
u/l
7.8
7.6
0.02
18
116
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
10
41
2.44
1.75
1.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
154
0.39
1.74
1.2
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
6
18
3.33
1.74
1.0
1.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1476
15580
0.93
1.74
3.3
2.8
ug/l
185.2
158.6
1.71
1325
13978
(3042517) Benzodiazepines panel - Urine
5
13
3.85
1.71
1.2
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
67
491
1.37
1.71
1.5
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
21
118
1.78
1.69
1.0
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
139
1701
0.81
1.66
1.2
1.2
iu/ml
70.9
127.5
1.98
43
576
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
132
1624
0.81
1.66
3.0
3.1
u/ml
608.9
2289.8
1.16
111
1367
(40760892) CBC W Ordered Manual Differential panel - Blood
704
7655
0.91
1.65
5.2
4.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1981
18974
1.07
1.62
4.6
3.9
estimate
0.0
0.0
0.00
363
3523
(3002621) Streptococcal DNAse B [Units/volume] in Serum
8
32
2.50
1.59
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
75
567
1.33
1.58
1.6
1.4
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
7
26
2.69
1.58
2.6
3.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
315
3577
0.87
1.57
1.8
2.1
ug/g
167.6
160.7
0.10
243
2781
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
30
191
1.57
1.56
1.3
1.1
u/l
108.2
80.7
0.46
21
148
(40758558) Short blood count panel - Blood
1039
9734
1.08
1.54
7.8
6.4
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
30
192
1.57
1.53
1.3
1.1
u/l
60.2
24.9
0.58
18
146
(3023323) Follitropin [Units/volume] in Serum or Plasma
72
547
1.32
1.49
1.4
1.4
iu/l
35.5
28.8
0.70
52
457
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
36
242
1.49
1.49
1.7
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
36
242
1.49
1.49
1.7
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
47
651
0.72
1.46
1.6
1.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
9
38
2.37
1.45
1.9
1.8
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
16
3.13
1.43
1.0
1.1
—
—
—
0
0
(4146454)
35
506
0.69
1.40
2.1
2.7
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
24
149
1.61
1.40
2.0
1.9
e6/l
322.0
1576.2
0.91
16
103
(40758292) HTLV I+II Ab panel - Serum
10
46
2.18
1.39
1.4
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
72
928
0.77
1.39
1.2
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
178
1513
1.18
1.38
2.5
3.0
g/l
0.3
0.3
0.11
95
612
(3008757) Leukocyte morphology finding [Identifier] in Blood
65
493
1.32
1.38
3.8
4.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
995
9350
1.08
1.37
1.4
1.3
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
142
1184
1.20
1.36
1.3
1.2
u/ml
2.5
1.1
0.32
13
118
(40768441) Liver Pathology biopsy report
34
231
1.47
1.36
1.8
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1278
13445
0.93
1.34
3.9
4.0
mg/mmol
18.2
9.5
3.59
856
8489
(3004616) Nuclear Ab [Presence] in Serum
28
416
0.67
1.31
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
93
1151
0.80
1.30
1.8
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
2285
22103
1.06
1.29
9.5
8.5
e9/l
4.6
4.3
3.90
1999
19002
(3023419) Bacteria identified in Sputum by Culture
72
560
1.29
1.29
2.0
2.5
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
18
2.78
1.28
1.8
1.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
55
413
1.33
1.27
2.6
2.3
u/field
3.9
1.6
0.97
20
143
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
120
1442
0.83
1.26
1.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
14
77
1.82
1.25
1.3
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
6
25
2.40
1.24
1.0
1.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
705
6568
1.08
1.22
3.1
2.4
g/l
2.2
2.3
2.66
635
5988
(3012516) Albumin [Mass/volume] in Urine
1206
12673
0.94
1.22
3.2
3.2
mg/l
613.4
328.2
1.12
821
8043
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
8
37
2.16
1.21
1.6
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
72
566
1.28
1.21
1.8
1.6
mu/l
284.8
292.0
0.11
66
523
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
6
26
2.31
1.18
1.2
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
145
1233
1.18
1.16
1.4
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
76
947
0.80
1.16
1.7
1.7
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
8
39
2.05
1.15
1.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
20
2.50
1.15
2.6
2.5
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
35
0.00
1.15
0.0
1.1
—
71.2
—
0
25
(3017732) Neutrophils [#/volume] in Blood
222
2516
0.88
1.15
3.1
3.2
e9/l
4.0
4.2
0.97
157
1780
(3005322) IgE [Units/volume] in Serum or Plasma
148
1727
0.85
1.14
1.2
1.3
u/ml
185.1
222.6
0.57
139
1575
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
46
610
0.75
1.14
1.1
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1992
19251
1.06
1.14
4.7
4.0
estimate
0.0
0.0
1.08
348
3439
(1002224) Polysomnography panel
77
954
0.80
1.12
1.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
8
40
2.00
1.12
1.0
1.0
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
18
111
1.62
1.11
1.3
1.3
g/l
11.0
14.4
0.81
12
86
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
212
2404
0.88
1.11
2.3
2.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
663
6191
1.08
1.10
3.3
2.5
%
21.5
21.7
0.15
559
5192
(3021440) Promyelocytes/100 leukocytes in Blood
289
3212
0.89
1.10
4.4
3.9
%
0.1
0.1
0.13
102
937
(3029396) Erythrocyte agglutination [Presence] in Blood
5
21
2.38
1.09
1.4
1.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
11
194
0.57
1.08
1.1
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
8
41
1.95
1.08
1.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
19
120
1.58
1.08
2.2
1.8
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
11
193
0.57
1.07
1.1
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
24
161
1.49
1.06
1.8
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
24
161
1.49
1.06
1.8
1.8
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
7
33
2.12
1.05
1.4
1.4
—
—
—
0
0
(3013512) EKG study
1215
12705
0.94
1.05
4.7
4.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
45
590
0.76
1.05
2.0
1.9
pmol/l
194.3
210.2
0.49
39
551
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
122
0.49
1.05
1.0
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
628
6704
0.93
1.01
1.2
1.2
u/ml
2.0
1.7
0.19
155
1652
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
10
53
1.89
1.01
1.6
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
149
1717
0.86
1.01
2.1
1.9
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
24
345
0.69
1.00
1.0
1.2
mmol/l
8.3
7.8
0.28
18
237
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
9
48
1.88
1.00
1.4
1.3
ug/l
64.4
97.5
—
9
28
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
575
5364
1.08
1.00
10.9
8.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
7
35
2.00
1.00
1.0
1.2
%
99.9
97.2
—
7
35
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
7
35
2.00
1.00
1.0
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
138
1188
1.17
0.99
1.6
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
65
520
1.25
0.99
1.5
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1762
18209
0.95
0.98
2.7
2.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
64
512
1.25
0.98
1.3
1.3
miu/ml
175.2
197.2
0.18
18
190
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
78
947
0.82
0.97
2.9
3.2
u/ml
1351.0
817.2
0.16
73
857
(21494434) Karyotype in Bone marrow
51
397
1.29
0.97
1.3
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
76
622
1.22
0.95
1.5
1.4
e6/l
43455.6
78457.9
1.01
47
372
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
32
233
1.38
0.95
2.9
2.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
9
51
1.77
0.94
5.3
2.8
u/field
0.7
0.4
—
9
51
(3011412) CD3 cells [#/volume] in Blood
42
320
1.31
0.94
2.5
2.1
e9/l
0.8
1.1
1.12
26
194
(3028192) IgG subclass 2 [Mass/volume] in Serum
39
294
1.33
0.93
1.2
1.3
g/l
2.9
2.9
0.00
33
208
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
26
363
0.71
0.93
1.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
19
125
1.52
0.93
1.5
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
120
0.50
0.93
1.2
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
462
4289
1.08
0.92
2.8
2.5
e9/l
71.7
67.9
1.13
337
3261
(40768443) Skin Pathology biopsy report
157
1787
0.87
0.91
1.3
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
24
167
1.44
0.91
1.3
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1957
19000
1.05
0.90
6.1
5.3
estimate
0.0
0.0
0.50
354
3538
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
14
219
0.64
0.90
2.0
1.5
pmol/l
108.3
193.5
—
7
68
(3016750) Collection duration of Urine
34
253
1.35
0.89
2.3
2.0
min
496.8
494.6
0.04
26
171
(3041096) Erythrocytes [Presence] in Urine by Automated
951
9965
0.94
0.89
4.6
3.8
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
5
102
0.49
0.89
1.0
1.1
—
2.2
—
0
37
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
49
385
1.27
0.89
1.6
1.6
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
23
160
1.44
0.88
6.5
6.5
mmol/l
26.5
24.4
1.45
23
144
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1866
18108
1.05
0.87
2.1
2.1
pmol/l
89.5
92.4
1.91
1012
9379
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
193
0.62
0.87
2.9
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
45
351
1.28
0.86
1.8
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
45
351
1.28
0.86
1.8
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
45
351
1.28
0.86
1.8
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
71
585
1.22
0.86
1.6
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
29
212
1.37
0.86
1.9
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
29
212
1.37
0.86
1.9
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
29
212
1.37
0.86
1.8
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
29
212
1.37
0.86
1.9
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
82
688
1.19
0.83
5.5
3.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
10
57
1.76
0.83
1.8
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
8
137
0.58
0.83
1.1
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
139
0.57
0.83
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
300
2750
1.10
0.82
3.9
3.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
23
163
1.41
0.81
1.9
1.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
271
2963
0.91
0.81
4.5
4.0
%
0.1
0.3
0.92
88
762
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
25
181
1.38
0.79
1.1
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
38
294
1.29
0.79
1.2
1.3
g/l
7.3
6.7
0.51
32
207
(3024139) IgG subclass 3 [Mass/volume] in Serum
38
294
1.29
0.79
1.2
1.3
g/l
0.4
0.4
0.09
33
207
(3006653) Thiamine [Moles/volume] in Blood
22
156
1.41
0.78
1.2
1.2
nmol/l
142.9
146.1
0.08
22
156
(3007164) IgA [Mass/volume] in Serum or Plasma
562
5957
0.94
0.78
1.5
1.5
g/l
3.0
2.7
1.93
339
3384
(3023199) Leukocytes [#/volume] in Pleural fluid
81
684
1.19
0.78
1.5
1.5
e6/l
4959.6
1716.8
0.44
59
493
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
62
511
1.22
0.77
1.4
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
20
140
1.43
0.76
2.2
1.7
ug/l
86.1
48.4
0.53
20
134
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
86
732
1.18
0.76
2.0
1.5
nmol/l
0.8
0.8
0.05
74
609
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
10
59
1.70
0.75
1.3
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
71
595
1.20
0.75
1.3
1.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
53
1.70
0.75
1.8
1.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
28
209
1.34
0.75
2.3
2.2
e6/l
355.3
509.2
1.23
23
176
(4062490)
38
297
1.28
0.75
1.2
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
58
477
1.22
0.74
1.5
1.4
g/l
0.8
0.8
0.04
51
359
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
20
278
0.72
0.74
1.4
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
29
380
0.76
0.73
1.2
1.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
7
38
1.84
0.73
1.1
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1505
14589
1.04
0.73
5.1
4.3
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
8
132
0.61
0.73
1.1
1.5
ug/l
4.3
9.0
—
8
114
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
11
68
1.62
0.71
6.5
7.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1250
12926
0.96
0.71
3.2
3.2
mmol/l
7.0
7.3
1.37
1029
10557
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
14
206
0.68
0.71
1.3
1.4
u/ml
0.3
1.6
—
8
104
(3003434) Protein [Mass/volume] in Pleural fluid
90
775
1.16
0.71
1.4
1.5
g/l
34.5
31.5
1.58
79
693
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
30
229
1.31
0.70
1.4
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
30
229
1.31
0.70
1.4
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
18
126
1.43
0.70
1.0
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
14
205
0.68
0.69
1.1
1.1
u/ml
5.2
3.3
—
5
78
(3000093) Morphology [Interpretation] in Blood Narrative
54
445
1.22
0.69
1.2
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
147
1313
1.12
0.69
1.5
1.6
titre
76.0
200.6
—
5
71
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
30
231
1.30
0.67
2.1
2.0
e6/l
468.5
608.4
0.93
12
97
(21494890) Protein electrophoresis panel - 24 hour Urine
41
507
0.81
0.67
2.1
1.9
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
5
93
0.54
0.66
1.2
1.1
—
22.8
—
0
12
(3047189) Immunofixation for 24 hour Urine
16
226
0.71
0.66
1.8
1.7
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
94
0.53
0.66
3.8
1.5
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
5
28
1.79
0.66
1.2
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
31
241
1.29
0.65
2.7
2.1
%
10.7
13.6
0.50
14
88
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
29
1.72
0.64
6.8
3.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
282
3035
0.92
0.63
4.3
3.8
%
1.0
0.6
0.90
79
705
(4211845)
28
216
1.30
0.63
3.3
3.9
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
30
234
1.28
0.62
3.0
1.8
u/field
1.5
2.6
0.71
21
163
(3045142) Bone marrow Pathology biopsy report
41
501
0.82
0.62
1.5
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
52
1.54
0.59
3.0
1.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
51
606
0.84
0.58
1.5
1.3
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
13
185
0.70
0.58
1.1
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
37
300
1.23
0.58
2.7
1.9
u/l
958.1
2228.4
0.54
12
117
(3023420) DNA double strand Ab [Units/volume] in Serum
37
300
1.23
0.58
2.4
1.3
iu/ml
24.4
20.6
—
5
8
(3044927) Protein electrophoresis panel - Urine
44
529
0.83
0.57
1.3
1.2
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
6
35
1.71
0.57
1.0
1.0
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
16
219
0.73
0.57
1.1
1.1
u/ml
5.3
1.6
—
7
84
(3014765) Yersinia sp identified in Stool by Organism specific culture
119
1065
1.12
0.57
1.2
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
185
1695
1.09
0.57
1.7
1.6
u/ml
16.1
19.8
—
7
44
(40759836) Histone Ab [Presence] in Serum by Immunoblot
26
202
1.29
0.57
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
26
202
1.29
0.57
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
26
202
1.29
0.57
1.3
1.1
—
—
—
0
0
(3036603) Volume of Urine
18
241
0.75
0.56
1.3
1.8
ml
1788.7
1811.2
—
7
61
(3000034) Microalbumin [Mass/volume] in Urine
46
383
1.20
0.56
3.6
3.3
mg/l
15.3
32.7
1.78
34
296
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
118
1057
1.12
0.56
1.2
1.2
—
—
—
0
0
(44813793)
13
183
0.71
0.55
1.1
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
105
1175
0.89
0.55
1.4
1.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
18
133
1.35
0.54
1.7
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1629
16667
0.97
0.54
12.4
10.1
e9/l
0.0
0.0
0.18
1337
13461
(42529406) Shigella sp [Presence] in Stool by Culture
119
1070
1.11
0.54
1.2
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
317
3369
0.94
0.53
4.4
3.9
%
1.3
1.0
1.29
113
1002
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
80
703
1.14
0.52
1.3
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
195
1800
1.09
0.52
3.1
3.2
pmol/l
4.1
4.4
3.85
165
1553
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
26
205
1.27
0.52
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
26
205
1.27
0.52
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
26
205
1.27
0.52
1.3
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
419
3976
1.06
0.52
2.3
2.5
g/l
65.2
66.0
1.21
370
3497
(3003888) Timothy IgE Ab [Units/volume] in Serum
23
293
0.78
0.52
1.1
1.0
u/ml
5.8
4.8
—
10
140
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
134
0.67
0.51
1.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
40
1.50
0.51
1.2
1.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
27
215
1.26
0.50
1.2
1.2
mmol/l
11.4
12.3
—
6
70
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
26
207
1.26
0.49
1.5
2.7
%
34.1
37.1
—
7
73
(3006462) Nitrate [Presence] in Urine
25
199
1.26
0.47
3.2
4.1
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
7
50
1.40
0.45
1.0
1.3
nmol/l
4.5
197506.4
—
7
40
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
70
789
0.89
0.44
1.4
1.2
u/ml
2.0
3.4
0.94
11
65
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
75
841
0.89
0.44
1.7
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
322
3392
0.95
0.43
5.9
4.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
23
285
0.81
0.43
1.1
1.0
u/ml
0.3
1.7
1.50
13
117
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
331
3144
1.06
0.42
3.7
2.7
ml/min/173m2
60.4
60.5
0.01
147
1377
(3036071) Salmonella sp Ab [Titer] in Serum
6
93
0.64
0.42
1.2
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
37
313
1.18
0.42
1.6
1.6
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
95
0.63
0.42
1.0
1.3
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
41.8
—
0
5
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
16.6
—
0
5
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
0.5
—
0
9
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1101
10738
1.03
0.41
1.6
1.6
nmol/l
18.6
20.0
1.90
978
9037
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
14
183
0.76
0.40
1.1
1.1
—
—
—
0
0
(4281824)
30
358
0.84
0.40
1.3
1.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
17
132
1.29
0.40
1.8
1.7
e6/l
1508.7
24103.2
—
7
77
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
104
0.67
0.39
1.3
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
28
335
0.83
0.39
1.1
1.1
u/ml
0.2
2.0
2.98
11
135
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
19
0.00
0.39
0.0
1.9
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
68
607
1.12
0.39
2.2
2.1
mg/l
27.2
26.4
0.02
11
154
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
40
344
1.16
0.38
1.1
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
16
124
1.29
0.38
2.6
1.9
—
—
—
0
0
(3000012) Reticulocyte production index
24
291
0.82
0.38
1.1
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
11
80
1.38
0.38
1.8
1.6
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
36
1.39
0.38
1.6
1.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
408
4252
0.96
0.38
1.6
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
22
269
0.82
0.38
1.4
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
72
800
0.90
0.38
1.4
1.2
u/ml
4.1
6.4
0.63
15
113
(3035320) C reactive protein [Mass/volume] in Body fluid
23
279
0.82
0.37
2.5
2.4
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
21
257
0.82
0.37
4.7
5.0
u/ml
39.0
52.9
—
8
65
(3020717) Zinc [Moles/volume] in Serum or Plasma
19
152
1.25
0.36
1.4
1.4
umol/l
21.1
22.9
0.10
19
146
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
54
478
1.13
0.36
2.0
1.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
77
0.65
0.35
1.6
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
9
123
0.73
0.35
1.2
1.7
ug/l
17.3
109.3
—
9
114
(3023511) Choriogonadotropin [Units/volume] in Urine
9
124
0.73
0.35
1.2
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
17
135
1.26
0.35
1.4
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1493
14669
1.02
0.34
3.4
3.2
ng/l
1885.3
1963.1
0.25
1299
12669
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
19
154
1.23
0.33
1.6
1.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
84
768
1.09
0.33
4.1
3.8
%
1.8
1.5
0.33
66
561
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
136
1455
0.93
0.33
1.7
1.8
u/l
39.2
38.7
0.07
115
1239
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
44
497
0.88
0.32
1.1
1.1
iu/ml
1.1
46.8
—
9
98
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
50
560
0.89
0.32
1.1
1.1
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
15
119
1.26
0.31
2.1
3.0
mu/l
26.6
26.2
0.01
15
111
(3000570) Elastase.pancreatic [Mass/mass] in Stool
108
1162
0.93
0.31
1.4
1.5
ug/g
217.6
266.8
1.74
58
720
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
76
695
1.09
0.30
1.1
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
7
54
1.30
0.30
1.0
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
199
2094
0.95
0.30
2.4
2.4
au/ml
29.0
24.5
—
8
71
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
58
640
0.90
0.29
1.2
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
19
228
0.83
0.29
1.3
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
47
524
0.90
0.29
1.3
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
110
0.73
0.28
1.1
1.2
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
14
112
1.25
0.28
1.4
1.5
umol/l
2.2
2.0
0.46
14
101
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
12
94
1.28
0.28
1.0
1.1
pmol/l
401.2
264.6
1.23
12
63
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
47
522
0.90
0.27
1.3
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
9
116
0.78
0.27
1.6
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
9
117
0.77
0.27
1.6
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
27
233
1.16
0.27
2.9
3.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
9
120
0.75
0.27
1.6
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
27
311
0.87
0.27
1.3
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
47
521
0.90
0.27
1.3
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
116
1089
1.07
0.26
2.4
2.3
ug/min
204.2
114.1
0.64
65
620
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
13
104
1.25
0.26
1.2
1.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
11
86
1.28
0.26
6.5
7.9
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
9
72
1.25
0.25
1.4
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
138
0.80
0.25
1.2
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
41
456
0.90
0.25
1.4
1.4
—
—
—
0
0
(3019225) pH of Specimen
462
4491
1.03
0.25
5.2
4.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
83
891
0.93
0.24
1.3
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
57
522
1.09
0.24
1.7
1.8
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
9
77
1.17
0.24
1.2
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
110
1035
1.06
0.24
1.5
1.5
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
11
87
1.26
0.24
2.3
1.9
ug/l
2.4
1.3
0.44
11
82
(3012441) Differential panel - Pleural fluid
66
610
1.08
0.23
1.5
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
43
474
0.91
0.23
1.4
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
136
0.81
0.23
1.4
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
215
2065
1.04
0.23
2.9
2.9
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
10
125
0.80
0.23
1.1
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
39
1.28
0.23
1.8
1.6
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
52
476
1.09
0.22
3.7
3.7
%
63.2
57.7
0.93
35
275
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
92
0.76
0.22
1.1
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
92
0.76
0.22
1.1
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
92
0.76
0.22
1.1
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
92
0.76
0.22
1.1
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
40
1.25
0.22
1.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
44
483
0.91
0.22
3.0
3.6
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
41
1.22
0.22
10.8
9.7
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
45
410
1.10
0.22
1.1
1.2
nmol/l
358.7
323.4
0.52
32
318
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
10
0.00
0.21
0.0
1.0
—
1198.9
—
0
10
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
12.3
—
0
11
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
11
0.00
0.21
0.0
1.1
—
7.7
—
0
11
(1761482) Bacteria [#/volume] in Urine by Culture
146
1393
1.05
0.21
4.2
4.6
—
—
—
0
0
(44806420)
15
177
0.85
0.21
2.5
2.4
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
3.4
—
0
13
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
1.9
—
0
8
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
26
293
0.89
0.20
1.8
1.8
ug/l
2.1
3.5
1.15
20
253
(3004588) Protein electrophoresis panel - Serum or Plasma
325
3345
0.97
0.20
2.2
2.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
32
287
1.12
0.20
1.1
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
14
0.00
0.20
0.0
9.4
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
0.8
—
0
8
(3041672) Baker's yeast Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
437
4264
1.03
0.20
1.4
1.3
titre
633.3
496.5
0.66
96
924
(3011544) Albumin [Mass/volume] in Pleural fluid
6
50
1.20
0.19
1.0
1.1
g/l
15.8
17.6
—
6
44
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
54
500
1.08
0.19
1.7
1.5
%
54.5
62.8
0.96
37
317
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
90
1.22
0.19
2.0
1.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
13
154
0.84
0.19
1.0
1.3
mmol/l
6.3
6.2
0.12
13
147
(3004775) Volume in Urine collected for unspecified duration
40
366
1.09
0.18
2.4
2.1
ml
738.3
633.8
0.59
30
208
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
30
270
1.11
0.18
1.8
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
28
311
0.90
0.18
1.3
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
16
185
0.86
0.18
2.0
1.4
%
4.4
2.5
—
8
42
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3084
30665
1.01
0.17
9.1
7.4
u/l
85.4
81.3
2.93
2892
28578
(3001186) Copper [Moles/volume] in Serum or Plasma
7
62
1.13
0.17
1.0
1.0
umol/l
19.6
16.6
—
7
54
(4035726)
365
3565
1.03
0.17
1.5
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
30
272
1.10
0.17
1.8
1.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
39
423
0.92
0.17
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
23
205
1.12
0.17
1.8
1.7
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
21
236
0.89
0.16
2.2
2.1
ug/min
132.9
129.5
—
7
59
(3017704) Immunofixation for Urine
31
282
1.10
0.16
1.7
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
187
1932
0.97
0.16
1.3
1.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
8
71
1.13
0.16
1.0
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
155
1606
0.96
0.16
2.8
2.3
g/l
1.0
1.3
0.35
132
1338
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
13
151
0.86
0.15
1.5
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
40
370
1.08
0.15
1.2
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34
312
1.09
0.15
1.8
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
77
0.78
0.15
1.2
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
6
78
0.77
0.15
1.2
1.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
12
140
0.86
0.15
2.4
2.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
12
102
1.18
0.15
1.9
2.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
49
523
0.94
0.15
1.3
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
183
1886
0.97
0.14
1.3
1.3
au/ml
61.0
56.5
—
9
77
(3002619) Bacteria identified in Specimen by Culture
9
83
1.08
0.14
1.2
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
86
0.81
0.14
1.1
1.4
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
7
86
0.81
0.14
1.6
3.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
96
1002
0.96
0.14
3.6
3.7
mg/l
29.3
30.0
0.05
67
674
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
13
112
1.16
0.14
1.2
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
75
787
0.95
0.14
5.4
3.6
%
61.6
58.6
1.31
75
787
(3051101) Glucose [Moles/volume] in Cord blood
8
99
0.81
0.13
2.9
6.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
35
377
0.93
0.13
2.0
1.4
%
28.4
24.4
0.34
25
233
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
100
960
1.04
0.13
1.9
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
65
684
0.95
0.13
2.2
2.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
34
366
0.93
0.13
1.4
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
50
530
0.94
0.13
1.3
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
169
1641
1.03
0.13
2.4
2.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
129
1247
1.04
0.13
2.9
3.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
16
142
1.13
0.12
2.7
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
42
447
0.94
0.12
1.3
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
10
85
1.18
0.12
1.5
1.5
ug/l
12.3
8.8
—
10
85
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
10
85
1.18
0.12
2.0
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
19
210
0.90
0.12
1.1
1.3
u/l
46.1
28.5
1.11
13
169
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
62
590
1.05
0.12
1.7
2.2
pg
32.3
32.5
0.14
62
585
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
44
414
1.06
0.12
1.7
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
972
9626
1.01
0.11
1.7
1.7
pmol/l
45019358.6
23185621.7
0.38
793
7673
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
49
516
0.95
0.11
1.3
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2974
29839
0.99
0.10
32.2
21.9
g/l
331.6
331.4
0.67
2919
29470
(3009214) Lutropin [Units/volume] in Serum or Plasma
61
583
1.05
0.10
1.4
1.4
u/l
13.5
9.7
1.01
47
465
(3044941) Cell count panel - Synovial fluid
64
667
0.96
0.10
1.3
1.4
—
—
—
0
0
(3001729) Color of Synovial fluid
5
44
1.14
0.10
1.6
1.5
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
15
166
0.90
0.09
1.1
1.4
%
32.6
18.4
0.99
15
150
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
68
707
0.96
0.09
1.5
1.7
iu/l
2.6
4.8
3.53
18
220
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
12
106
1.13
0.09
1.3
1.3
%
22.6
31.1
—
5
72
(3027035) Albumin [Mass/time] in 24 hour Urine
5
46
1.09
0.09
1.8
1.3
—
829.1
—
0
7
(4024509)
41
432
0.95
0.09
1.8
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
79
818
0.96
0.09
2.4
1.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
169
1652
1.02
0.09
2.8
3.1
mg/l
33.2
61.1
2.21
140
1329
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
13
145
0.90
0.09
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
13
145
0.90
0.09
1.4
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
36
380
0.95
0.09
1.1
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
14
126
1.11
0.09
1.4
1.4
umol/l
24.4
29.9
1.64
14
121
(3032773) Endomysium IgG Ab [Titer] in Serum
24
257
0.93
0.08
1.0
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
13
144
0.90
0.08
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
13
144
0.90
0.08
1.4
1.4
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
61
0.82
0.08
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
230
2338
0.98
0.08
1.2
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
5
64
0.78
0.08
1.4
1.8
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
64
0.78
0.08
1.0
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2808
27995
1.01
0.07
4.3
4.1
mm/h
15.6
14.6
2.26
2618
25288
(3014599) Egg white IgE Ab [Units/volume] in Serum
8
91
0.88
0.06
1.0
1.1
—
2.0
—
0
28
(3025577) Chromium [Mass/volume] in Blood
27
285
0.95
0.06
1.8
2.0
ug/l
1.8
2.0
0.24
22
239
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
19
177
1.07
0.06
1.0
1.0
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
168
1652
1.02
0.06
2.8
3.1
mg/l
46.6
99.6
0.88
139
1324
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
17
182
0.93
0.05
5.4
6.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
27
257
1.05
0.05
3.0
4.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
11
100
1.10
0.05
2.4
3.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
176
1736
1.01
0.05
2.6
2.3
g/l
3.2
3.1
0.41
134
1342
(3020491) Glucose [Moles/volume] in Blood
30
287
1.05
0.05
1.6
2.3
mmol/l
6.8
6.9
0.07
19
192
(3037756) Immunofixation for Serum or Plasma
107
1089
0.98
0.05
1.5
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
140
1379
1.02
0.05
1.2
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
14
150
0.93
0.04
1.6
1.5
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
11
101
1.09
0.04
6.5
7.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
129
1272
1.01
0.04
2.5
2.2
g/l
0.0
0.0
0.00
118
1157
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
175
1769
0.99
0.04
2.7
2.3
g/l
10.5
10.3
0.19
143
1469
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
119
0.92
0.04
1.2
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
74
754
0.98
0.03
1.2
1.3
u/l
35.1
46.0
0.37
63
642
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
30
311
0.96
0.03
1.5
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
32
309
1.04
0.03
1.3
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
28
270
1.04
0.03
1.3
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
163
1614
1.01
0.03
2.8
3.1
ratio
3.5
3.6
0.00
11
110
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
34
330
1.03
0.03
1.3
1.2
nmol/l
1.5
1.4
0.23
25
296
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3757
37530
1.00
0.02
25.8
16.6
mg/l
26.9
27.8
1.07
3404
30628
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
131
1296
1.01
0.02
2.5
2.2
g/l
0.0
0.0
0.79
118
1162
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
40
390
1.03
0.02
1.3
1.6
u/ml
44.1
26.6
—
9
89
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
145
1461
0.99
0.02
2.6
2.1
g/l
35.3
37.2
3.36
126
1219
(3000475) Leukocytes [#/volume] in Synovial fluid
102
1030
0.99
0.02
1.6
1.6
e6/l
12131.9
15288.2
0.56
69
727
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
187
1881
0.99
0.02
2.6
2.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
38
388
0.98
0.01
1.1
1.1
—
10.7
—
0
17
(3013727) Leukocytes other/100 leukocytes in Blood
15
157
0.96
0.01
4.2
3.8
%
40.4
54.7
1.94
15
146
(3036670) Protein [Mass/volume] in Synovial fluid
16
153
1.05
0.01
1.3
1.2
g/l
40.8
39.5
—
10
72
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
17
163
1.04
0.01
1.7
1.5
g/l
0.9
1.0
0.07
17
163
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
39
383
1.02
0.01
1.3
1.5
u/l
12.8
13.6
0.38
39
368
(3000330) Specific gravity of Urine by Test strip
237
2378
1.00
0.01
3.6
3.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
139
1382
1.01
0.01
2.5
2.2
g/l
0.0
0.1
2.95
126
1243
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1584
15825
1.00
0.00
2.3
2.2
nmol/l
75.5
79.2
5.73
1389
13692
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
14
134
1.04
0.00
1.1
2.0
u/l
11.8
56.3
1.68
14
125
(3050129) First trimester maternal screen panel - Serum or Plasma
18
174
1.03
0.00
1.6
1.5
—
—
—
0
0
(4015189)
12
122
0.98
0.00
2.1
2.6
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
17
170
1.00
0.00
1.2
1.3
ug/l
582.7
421.2
—
7
90
(3014051) Protein [Presence] in Urine by Test strip
91
905
1.01
0.00
2.4
2.2
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
19
187
1.02
0.00
1.6
1.2
u/l
288.5
345.7
0.19
19
175
(3021788) Differential panel - Synovial fluid
77
771
1.00
0.00
1.6
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
91
912
1.00
0.00
1.5
1.9
mg/l
13.0
11.8
0.43
80
831
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
189
1884
1.00
0.00
2.6
2.3
g/l
7.5
7.5
0.05
136
1368
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
188
1878
1.00
0.00
2.6
2.3
g/l
3.9
3.8
0.62
133
1317
(3010144) Erythrocytes [#/volume] in Synovial fluid
41
405
1.01
0.00
1.4
1.3
e6/l
86041.2
65040.0
0.15
26
274
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
98
976
1.00
0.00
1.5
1.6
iu/ml
0.1
11.4
0.95
30
229
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
2.3
—
2.6
—
0
7
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
6
59
1.02
0.00
1.0
1.2
mg/l
16.4
5.9
—
6
53
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
1614.3
—
0
7
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.4
—
2.7
—
0
7
(3013336) Amino acids [Identifier] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
8
80
1.00
0.00
1.0
1.0
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
8
80
1.00
0.00
1.1
1.2
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
9
99
0.91
0.00
2.1
2.2
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
8
0.00
0.00
0.0
6.6
—
31.6
—
0
8
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.5
—
2.1
—
0
8
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
64
0.94
0.00
5.7
1.7
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.3
—
0
5
(3006567) Chloride [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
7
71
0.99
0.00
1.0
1.1
—
8.5
—
0
12
Mortality – FinRegistry
↥Association
Association between endpoint I9_ICH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_ICH | 2.719 [2.45, 3.02] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.029 |
During the follow-up period (1.1.1998 — 31.12.2019), 8418 out of 15911 females with I9_ICH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_ICH | 2.682 [2.41, 2.99] | < 0.001 |
| Birth year | 0.984 [0.98, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 9468 out of 18816 males with I9_ICH died.
Mortality risk
Mortality risk for people of age
years, who have I9_ICH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.171% | 0.377% |
| 5 | 1.531% | 2.647% |
| 10 | 3.57% | 6.822% |
| 15 | 6.276% | 12.305% |
| 20 | 11.045% | 20.278% |
Relationships between endpoints
↥Index endpoint: I9_ICH – Intracerebral haemorrhage
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data